MODULATION OF UBIQUITINATION PATHWAY BY LEGIONELLA SidE EFFECTOR FAMILY by Akturk, Anil
 
 
 
 
 
 
MODULATION OF UBIQUITINATION PATHWAY BY LEGIONELLA SidE EFFECTOR 
FAMILY 
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School of  
Cornell University 
In Partial Fulfillment of the Requirements for the Degree of  
Doctor of Philosophy 
 
 
By 
Anil Akturk 
May 2018 
 
 
 
 
 
 
 
 
 
 
 
© 2018 Anil Akturk 
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FAMILY 
ABSTRACT 
 
 
Anil Akturk 
Cornell University 2018 
Legionella pneumophila manipulates a wide array of host cellular processes during 
infection; one that appears to be highly altered is the ubiquitination pathway. The SidE family of 
Legionella effector proteins has been shown to modify target proteins via a novel ubiquitination 
pathway, in which phosphoribosyl-ubiquitin is generated and subsequently used to ubiquitinate 
proteins. To elucidate the biochemical mechanism of this novel modification, we have solved the 
crystal structure of the catalytic core of SidE family member, SdeA. Using biochemical activity 
assays, we discovered an unpredicted domain that is crucial for the first step of this novel 
modification. To elucidate the molecular mechanism, we co-crystallized another SidE family 
member, SdeD, with both unmodified and modified ubiquitin molecules. These structural studies 
gave insights into the mechanism of ubiquitin modification during the second step of the reaction. 
We have also shown that two of the small SidE family members, SdeD and SdeF, remove the SdeA 
ubiquitin modification in an activity dependent manner, thus functioning as a deubiquitinase 
towards SdeA target proteins. These deubiquitinase proteins have also been shown to revert the 
 
 
phenotype exerted by SdeA in host cells. Altogether, this work provides a mechanistic insight into 
a novel ubiquitination reaction catalyzed by SdeA, in addition to providing a preliminary model 
for regulation of this enzymatic activity.  
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CHAPTER 1 
 
LEGIONELLA SECRETED SidE EFFECTOR FAMILY and OTHER EFFECTORS DURING 
INFECTION 
 
1.1 Legionella pneumophila  
Legionella pneumophila is a Gram-negative, non-sporulated, flagellated bacterium [1]. It 
is non-capsulated and characterized to be an aerobic bacillus under the coccobacillus shape 
structure [2]. At least 70 different serovars of Legionella have been identified depending on where 
they were found and the antigens they have on their surfaces [3]. Free-living amoeba in aquatic 
environments such as ponds are the natural hosts of these bacteria. Ten amoeba species and two 
other ciliated species have been shown to be host cells for Legionella [4]. Advances in air-
conditioning technologies, specifically the newer water-cooled air conditioning systems, introduce  
the possibility of contamination first with amoeba and then its pathogen Legionella [5]. When the 
Legionella contaminated aerosols are dispersed in the artificial atmosphere of automated buildings 
and inhaled by individuals, Legionnaire’s disease can be contracted.  
Legionnaire’s disease is a result of Legionellosis. The other outcome of this Legionellosis 
can be Pontiac fever which is a mild flu-like disease [6]. Legionnaire’s disease is a severe form of 
nonzoonotic atypical pneumonia that was first observed in a Legionnaire’s Convention in 
Philadelphia in 1976 [7]. Even though the cure for the disease is as easy as using a cocktail of 
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antimicrobial drugs (quinolones, azithromycin, rifampin, tigecycline and TMP-SMX) [8], case 
fatality rate for the disease is around 10%. The elderly, children, and people with lung pathologies 
(i.e. smokers) have a higher chance of morbidity [9]. Legionnaire’s Disease is a public health 
problem in developing countries but still up to 18 cases/million people can be encountered in 
developed countries such as the United States, Canada and the European Union [10]. Recent 
studies also show heart infection in the form of pericarditis, myocarditis and valvular infection by 
Legionella spp [11]. 
1.2 Legionella infection cycle 
At the cellular level, Legionella infection in alveolar macrophages and amoebas happen in 
a similar fashion (Fig.1-1). The whole cycle starts with the attachment of Legionella to the plasma 
membrane of the host cell. RtxA and PilEL proteins are involved in the attachment and entry of 
the bacterium. PilEL is reported to be similar to pili forming proteins from other Gram-negative 
bacterium species, but the function of RtxA remains unknown [12]. The surface protein that 
Legionella uses for attachment differs according to the host cell species: in amoeba cells, the 
bacterium mainly exploits N-acetylglucosamine containing lectin [13]; in contrast, on the surface 
of alveolar macrophages, the attachment of Legionella is mediated by complement receptors CR1 
(CD35) and CR3 (CD18/CD11b) [14]. When it attaches to the surface, the host cell internalizes 
the bacterium by phagocytosis. Pseudopods are used by both macrophages and amoebas to engulf 
Legionella. Because of the extensive movement of the host membrane around the bacteria, the 
cytoskeletal system plays a major role [15].  
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Figure 1-1: Legionella lifecycle inside the host 
cell. The whole process can be divided into two 
parts: pre- and post- Legionella containing 
vacuole (LCV) formation. Host cell pathway 
manipulations differ according to the presence 
of an LCV within the host cell.  
 
 
 
The most crucial aspect of Legionella infection is the secretion of effector proteins by the 
Dot/Icm type IVB secretion system (T4BSS). When the bacteria lack the secretory complex (which 
is generally denoted as ΔdotA for the dotA gene deletion), infectability is completely diminished 
in both macrophages and amoeba[16]. The complex is found in Gram-negative bacteria and in 
some archaea species. T4B systems are classified into two groups: 4A and 4B. The most studied 
example of the Type IVA system is found in Agrobacterium tumefaciens and is used by the 
organism to transfer DNA into the host plant cells. The Type IVB system is found in Coxiella and 
Legionella species mainly for translocation of effector proteins [17]. There are numerous studies 
to understand the architecture of the secretion system and the most prominent results have been 
obtained by the Cryo-EM structures. According to recent findings, the system consists of a Hat 
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region interacting with the outer membrane layer; a Stem complex to bridge the Stalk and Hat 
domains; a Stalk domain to bridge the intracellular space to the cytosolic space; Wings that help 
the localization of Stalk on the membrane; and Rods that help the effector proteins’ translocation 
from the Stalk domain. The whole complex consists of 25 different subunits and more than 100 
molecules [18]. More than 330 effector proteins have been reported to have been secreted or 
identified as substrates for the secretion system [19]. These effector proteins hijack different host 
pathways, mainly for creating a suitable environment for Legionella containing vacuole (LCV) 
formation. This will be discussed later.  
LCV is the continuation of the phagosome formed by the engulfment of Legionella. Even 
though it starts as a phagosome, studies showed that the internal pH is kept in a neutral range 
during formation and returns to an acidic level right before egress [20]. It is thought that this 
process is achieved by targeting the V-ATPase proton pumps located on the LCV with the effector 
protein SidK inhibiting activity of the pump [21]. The main purpose of Legionella to form LCVs 
is to evade the host phagolysosomal degradation pathway. Once a phagosome is formed by 
macrophages (or by amoeba cells in a similar fashion), the vesicle is destined to fuse with the 
lysosome and the content of the internalized material gets degraded. With  LCV formation, the 
phagosome can evade the fusion and “camouflage” itself as a part of the host cell [22]. The evasion 
by camouflage is achieved by recruiting small vesicles that are destined from Endoplasmic 
reticulum to the Golgi around the LCV. Rab1 and Arl1 molecules have been shown to be collected 
around LCV by the effectors SidM and RalF, respectively, that act as a Guanine Exchange Factor 
(GEF) for the GTPases [23, 24]. The activation of GTPases help recruit small vesicles around the 
LCV, although this notion has been challenged by recent studies that show how 
phosphoribose(PR)-ubiquitination of ER resident proteins by SdeA cause a long tubular extension 
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from the ER to the LCV instead of individual small vesicles [25]. At this stage, LCV resembles 
smooth ER. Recruitment of ribosomes, whose mechanism remains elusive, creates the “illusion” 
of hiding the LCV as a rough ER [26]. As expected, the division of the bacteria and the 
development phases requires a great deal of energy. This need is met by the recruitment of 
mitochondria around the LCV [27]. Effector proteins sneak in as SNARE proteins, such as LncP, 
LegS2 and LegS7, and induce the binding of mitochondria to the LCV [28, 29]. Host cells deficient 
in mitochondria formation show almost no LCV formation and Legionella growth [30]. When the 
replication cycle of Legionella has been achieved and development of Legionella bacteria is 
finalized (the formation of flagellum [31]), the bacteria gets ready to egress from the host cell. 
Even though the whole process of egress has not been elucidated, formation of an egress pore has 
been observed that is essential for the lysis of the host cell [32].  
1.3 Pathways modified by Legionella 
During infection, Legionella modifies different host cellular pathways to promote the 
formation and development of LCV and replicate within it. The effector proteins secreted are 
involved in manipulating these pathways within a very tightly regulated scheme of functionality 
[33] (Table1-1). Most of these functions are essential from the initial stage of phagocytosis. Even 
though there is a huge redundancy within the effector protein repertoire, deletion of certain effector 
genes causes the loss of infection ability for Legionella [34].  
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Small GTPases 
Effector secretion system T4BSS interacts with the membrane during phagocytosis and 
phagosome formation. Effector secretion starts as early as the phagosome formation and inclusion 
to the host cell. The triggering signal for effector secretion remains elusive [35]. As the main goal 
of the infection cycle is to form and maintain LCV, two main pathways need to be modified almost 
immediately: modulation of host vesicle trafficking to “steal” ER to Golgi destined anterograde 
vesicles and derailing from the lysosome fusion pathway [36]. Ras-like Small GTPases, Rab 
proteins, govern the regulation pathway of vesicle trafficking in cells. These molecules are inactive 
when a GDP molecule is located within their nucleotide binding pocket and they get activated and 
go under a conformational change to let their membrane-interacting alpha helical anchor get 
lipidated and bind to their respective membrane surfaces [37]. Rab1 and Arf1 are two small 
GTPases that regulate trafficking from ER to Golgi and these two proteins are among the first 
targets of Legionella effectors [38]. SidM/DrrA acts as a GEF for the Rab1 molecule by both its 
native function of exchanging GDP with GTP and forcing Rab1 to dissociate from its guanosine 
nucleotide dissociation inhibitor (GDI) [39]. SidM increases the activity of Rab1 by AMPylating 
its Tyr77 and blocks access to its GTPase Activation Proteins (GAP). This way, Rab1 gets more 
active and helps to recruit more membrane to the LCV [40]. Rab1 is returned to its normal state 
after getting deAMPylated by SidD effector protein so the LepB GAP molecule can start the 
deactivation process of Rab1[41, 42]. Effector AnkX phosphocholinates Rab1 to inhibit its activity 
further and Lem3 effector acts on Rab1 to de-phosphocholinate it only on LCV and keeps Rab1 
active on LCV [43] This whole Rab1 modification by Legionella effectors is a great example for 
the importance of the consecutive secretion of effectors into the host cell and the essentiality of 
the timing of the activity of these effectors for the continuation of the infection cycle [44].  
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Vesicle recruitment is not the only branch of membrane trafficking that Legionella 
interferes with. To inhibit the fusion of phagosome that contains the LCV, Legionella must evade 
the lysosomal degradation pathway. Rab35, which is localized on endosomes, has been shown to 
be phosphocholinated by AnkX to inhibit its activity at the early stages of infection. It was 
speculated that the inactivation of Rab35 by AnkX might inhibit the cargo sorting, thus inhibiting 
the endosome maturation process [43, 45]. Like SidM acting on Rab1, another effector, Lpg0393, 
is shown to act as a general GEF molecule for different Rab molecules including Rab5 and Rab21, 
which are heavily involved in endosomal maturation; and their modulation affects the transport of 
LCV to lysosomes [46]. Another study also showed the effector LegG1 to have GEF activity 
towards RAN GTPase which is involved in promoting microtubule stabilization and LCV 
mobility, again hypothesized to be inhibiting the interaction of lysosomes with the LCV [47, 48]. 
Vesicle trafficking is shown to be strongly connected to actin metabolism as well and Legionella 
effector repertoire contains proteins that modulate the actin pathway. VipA molecule associates 
with actin bundles around multi vesicular bodies (MVBs) and is shown to be an actin nucleator 
that inhibits the new bundle formation for the motility of the vesicle [49]. LegK2 protein inhibits 
the activity of ARP2/3 actin nucleator complex by phosphorylating the ARPC1B and ARP3 
subunits [50]. 
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Protein Name gene_id Annotation Reference 
AnkX lpg0695  Phosphocholine transferase Mukherjee, 2011 
Ceg14 lpg0437  Inhibition of actin polymerization Guo, 2014 
ceg15 lpg0439  Phospholipase A2 Zusman, 2007 
ceg18 lpg0898  Activates caspase 3 Zhu, 2013 
Ceg19 lpg1121  Possible dna binding domain Burstein, 2009 
Ceg2 lpg0059  Possible MCF transporter Huang, 2010 
Ceg22 lpg1484  peptidase (low chance kinase) Zusman, 2007 
Ceg28 lpg2311  Interaptin Huang, 2010 
Ceg4 lpg0096  haloacid dehalogenase-like hydrolase Huang, 2010 
Ceg9 lpg0246  
Interaction with Reticulon 4,  
manipulate secretory trafficking Haenssler, 2015 
GobX lpg2155  E3 Ub ligase Lin, 2015 
LecA lpg1692  
F-boxdomain-containing protein,  
manipulates host phospholipid biosynthesis Viner, 2012 
legA7 lpg0403  ankyrin-repeat containing protein Habyarimana, 2008 
LegAS4/RomA lpg1718  Methyltransferase Rolando, 2013 
LegAU13 /AnkB lpg2144  Fbox protein, ankyrin repeat, E3 ub ligase Price, 2011 
LegC3 lpg1701  
kinectin1 - kinesin receptor,  
involved in subversion of vesicle trafficking de Felipe, 2008 
LegC5/Lgt3 lpg1488  Glucosyl transferase Shen, 2009 
LegC7(YlfA) lpg2298  SNARE mimicry O'Brian, 2015 
LegC8/Lgt2 lpg2862  glucosyltransferase Belyi, 2008 
LegG1/PieG lpg1976  UVB-resistance protein UVR8 (potential GAP) Simon, 2014 
LegK1 lpg1483  Serine/threonine protein kinase Ge, 2009 
LegK2 lpg2137  kinase/ATP interaction Michard, 2015 
LegS2/LpSPL lpg2176  sphingosine-1 phosphate lyase Sheedlo, 2015 
LegU1 lpg0171  E3 Ubiquitin Ligase Ensminger, 2010 
LegU2/LubX lpg2830  E3 ub ligase Kubori, 2010 
Lem10 lpg1496  SidE member (contains PDE) Wong, 2015 
Lem12 lpg1625  involved in caspase 3 activation Zhu, 2013 
Lem14 lpg1851  Structural paralog og lpg0634(LpiR1) Beyrakhova, 2016 
Lem3 lpg0696  PC hydrolase Tan, 2011 
Lem7 lpg1145  Possible RNA binding domain Burstein, 2009 
LepB lpg2490  myosin like domain/Rab1 GAP Preissler, 2017 
Lgt1 lpg1368  Glucosyltransferase Belyi, 2018 
LpdA lpg1888  Phohspholipase D Viner, 2012 
MavA lpg1687  Ankyrin repeat Huang, 2010 
MavB lpg1752  metallophosphoesterase Huang, 2010 
MavJ lpg2498  Helicase Huang, 2010 
MavK lpg2525  Fbox and WD40 repeat containing Huang, 2010 
MavN/IroT lpg2815  Iron Transport Isaac, 2015 
MavQ lpg2975  ribosomal RNA large subunit methyltransferase Huang, 2010 
MavR lpg0209  Serine kinase Zusman, 2007 
MavU lpg1798  slit-robo rho GTPase activating Huang, 2010 
MavW lpg2907 Ubiquitin-like protease Catic, 2007 
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PieA/LirC lpg1963  Alteration of lysosome morphology Ninio, 2009 
PieE lpg1969  Binds Rab1, 5, 6, 7, 10 Mousnier, 2014 
pkn5/Ceg6 lpg0208  ser/thr/ kinase Havey, 2015 
PlcC/CegC1 lpg0012  phosphatidylcholine-hydrolyzing phospholipase Aurass, 2013 
PpiB lpg1962  Peptidyl-prolyl cis-trans isomerase (ppiA) Soderberg, 2007 
RalF lpg1950  Arf1 GEF Nagai, 2002 
RavJ lpg0944  Accumulates F-actin Liu, 2017 
RavK(SidK ortholog) lpg0969  Metalloprotease Liu, 2017 
RavL lpg1108  Putative lipase Huang, 2010 
RavN lpg1111  acyl transferase Huang, 2010 
RavO lpg1129  Metaeffector for lpg0208 Havey, 2015 
RavP lpg1152  3,4-dihydroxy-2-butanone-4-phosphate synthase Huang, 2010 
RavR lpg1166  Coiled coil protein Huang, 2010 
RavS lpg1183  Chaperone Huang, 2010 
RavX lpg1489  protein synthesis inhibition Copenhaver, 2015 
RavZ lpg1683  ATG8 Cysteine protease Choy, 2012 
rvfA lpg1797  coiled coil protein Huang, 2010 
sdbA lpg0275  alpha/beta hydrolase Bartfield, 2009 
sdbC lpg2391  alpha/beta hydrolase Huang, 2010 
sdcA lpg2510  E3 Ub Ligase Hsu, 2014 
sdeA lpg2157  SidE member Bhogaraju, 2016 
sdeB lpg2156  SidE member Bhogaraju, 2016 
sdeC lpg2153  SidE member Bhogaraju, 2016 
sdeD lpg2509  SidE member (contains PDE) Bhogaraju, 2016 
sdeF lpg2154  SidE member (contains PDE) Bhogaraju, 2016 
sdjA lpg2155  DUB of PR-Ub Qiu, 2017 
SdmB lpg2603  contains DrrA P4M domain Huang, 2010 
SetA lpg1978  Glucosyl-transferase Heidtman, 2009 
SidC lpg2511  E3 Ub Ligase Hsu, 2014 
SidD lpg2465  Adenosine monophosphate-protein hydrolase Neunuebel. 2011 
SidE  lpg0234  mART, PDE, DUB Bhogaraju, 2016 
SidF lpg2584  PI phosphatase Hsu, 2012 
SidJ lpg2508  PR-Ub DUB  
SidK lpg0968  Coiled coil protein (binds V-ATPase) Zhao, 2017 
SidM member lpg1101  PI4P binding Hubber, 2014 
SidM/DrrA lpg2464  Rab1 Ampylation Brombacher, 2009 
SidP lpg0130  PI phosphatase Toulabi, 2013 
StuC lpg2146  Sensor histidine kinase Loza-Correa, 2014 
VipA lpg0390  Actin Nucleator Franco, 2012 
VipD lpg2831  Patatin-like phospholipase Gaspar, 2014 
VipE lpg2813 Patatin-like phospholipase Shohdy, 2005 
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Table 1-1: List of Legionella effector proteins with reported functions. Various host cellular 
pathways are manipulated by the effector proteins of Legionella pneumophila. Approximately 
30% of effectors (among 330) have either known function or a role during infection.  
Phospholipids 
Host proteins are not the only targets of Legionella effectors. Small molecules like 
phospholipids are heavily modified during infection. Phosphoinositides (PIs), a subclass of 
phospholipids that have an inositol ring as a head group, act as organelle identifiers. Different 
proteins can bind to different phosphorylated states of the inositol ring (phosphorylation 
permutation on third, fourth, and fifth carbon atoms) [51]. Legionella effectors have been reported 
to either bind to these PI molecules or directly modify the phosphorylation state. One of the first 
evidences of PI re-modulation by Legionella was shown on the LCV: Regular phagosomes 
possesses PI(4,5)P2 on the surface, because it is the major PIP on the plasma membrane; then the 
PIPs are converted to PI(3)P on early endosome and PI(3,5)P2 on late endosome and lysosomes 
[52]; but the LCV surface was reported to have PI(4)P on the membrane, which is an indicator for 
the Golgi or plasma membrane, not the phagosome [53]. The exact mechanism of PI(4)P 
enrichment is not elucidated, but two effector proteins are acting directly on the PIPs on LCV: PI3 
phosphatases SidF and SidP. SidF removes P3 from PI(3,4,5)P3 and PI(3,4)P2 and SidP removes 
from PI(3)P directly [54, 55]. Effector LpnE indirectly helps with the PI(4)P accumulation by 
recruiting OCRL1, a 5-phosphatase that acts on PI(4,5)P2, to the LCV [56]. Phosphatases and 
kinases are not the only enzymes acting on PIPs by Legionella. VipD is a phospholipase A that 
acts on PI(3)P to a lysophopholipid and a fatty acyl chain. The protein is recruited by Rab5 and 
VipF lpg0103  N-acetyltransferase activity Young, 2016 
VipF lpg1227  Patatin-like phospholipase Shohdy, 2005 
VpdA lpg2410  Vipd ortholog (patatin like phospholipase) Shohdy, 2005 
wipB lpg0642  Ser/Thr Phosphatase  Prevost, 2017 
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Rab22 so it can be located on LCV during the early endosomal stage and stay on LCV during 
infection [57]. LpSpl and its homolog LegS2 are both sphingosine-1-phosphate lyases that act on 
sphingomyelins and modulate autophagy [58]. Some effectors use PIPs only for localizing at 
certain locations in the cell. PI(3)P and PI(4)P are main PIPs that effectors interact with during the 
infection [53]. SidM, Rab1 GEF, binds to PI(4)P on the LCV [23]; SidC, an E3 Ubiquitin ligase 
that will be discussed further, again binds to PI(4)P on the LCV [59]; LidA, which binds to Rab1-
GTP to keep it activated, performs the same binding to PI(4)P as well [60]; and finally altough the 
functions of Lpg1101 and Lpg2603 are not known, they are shown to bind PI(4)P, too [61]. PI(3)P 
binding effectors spread throughout the cell during infection. RidL, retrograde trafficking inhibitor 
that binds to retromer complex directly, binds to PI(3)P on early endosomes [62]; SetA, a glucosyl-
transferase, has a PI(3)P binding domain that causes bridging of vesicles [63]; LtpD, effector with 
no reported function, binds to the remaining PI(3)P pool on LCV and early endosomes [64].  
1.4 Modulation of Ubiquitination  
Ubiquitin is a small protein made up of 76 amino acids and is one of the most studied 
molecules in molecular biology. The molecule is used in a post-translational modification called 
ubiquitination in almost all eukaryotic cells [65]. The modification has been linked to various 
cellular pathways including protein degradation, inflammation, endocytosis, Histone regulation, 
DNA repair, and cell cycle [66-68]. Canonical ubiquitination involves three types of enzyme: a 
ubiquitin activation enzyme E1, a ubiquitin conjugating enzyme E2, and a ubiquitin ligase E3  
(Figure 1-2) [69]. The cascade starts with the ubiquitin being activated by E1 by forming a thioester 
linkage between the G76 of ubiquitin and the cysteine residue in the active site of E1. The energy 
needed to form the bond is obtained from ATP. The “activated” ubiquitin is transferred to an E2 
molecule and then an E2-Ub thioester intermediate state forms. Next, ubiquitin is transferred from 
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the E2 to the surface-accessible lysine residue of a substrate with the help of the E3 ligase enzyme. 
E3 ubiquitin ligase enzyme transfers ubiquitin molecules to its target proteins, which is detailed 
below [70]. Ubiquitin itself has seven lysine residues and the activating glycine residue that helps 
ubiquitination machinery to create complex ubiquitination branches or just polyubiquitin chains 
on substrates. The lysine residue used for ubiquitination also determines the fate of the substrate. 
One of the most studied lysine resides, K48, destines the proteins to proteolysis. This specific 
ubiquitination is recognized by the 26S subunit of proteasome [71]; another example is K63 linked 
polyubiquitin chains that act as a secondary messenger involved in inflammatory responses [72]. 
This whole ubiquitination process is reversible like most of the other post-translational 
modifications. There are enzymes called deubiquitinases (DUBs) that cleave the isopeptide bond 
between ubiquitin and the substrate [73]. The enzymatic activity of E1 and E2 enzymes are not 
distinct, but there are two main E3 ligases that recognize their substrates in different ways. HECT 
(homologous to the E3AP C-terminus) type E3 ligases form an intermediate with the activated 
ubiquitin molecule through a thioester bond with the cysteine residue in the active site and transfer 
it to the substrate in a two-step reaction [74]; whereas the RING (really interesting new gene) or 
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U-box type E3 ligases modulate the transfer of ubiquitin from the activated E2 molecule directly 
to the substrate protein. No intermediate is formed by RING domain ligation [75].    
 
 
 
 
 
 
 
 
Figure 1-2: Conventional Ubiquitination Pathway and Subversion by Bacterial E3 Ligase 
Effectors. Conventional ubiquitination requires the enzyme cascade of E1, E2, and E3 for 
ubiquitination of target proteins. Pathogenic bacteria secrete effectors that behave as E3 ligases 
and manipulate the ubiquitination pathway.  
 
Modification by ubiquitination is specific to eukaryotic cells. Even though bacteria have a 
prokaryotic ubiquitin-like protein (Pup) system, this is not as complex and highly regulated as 
ubiquitination and its machinery [76]. During infection, ubiquitination machinery targets 
phagosomal membrane proteins to direct the organelle for autophagy and the effector proteins 
secreted for degradation as an innate immunity response [77]. To use this machinery for infection, 
through horizontal gene transfer, various bacteria species have “stolen” the ubiquitination enzymes 
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and added them to their “arsenal” [78]. Evolutionarily, because bacteria either use the ubiquitin 
directly or divert the ubiquitination machinery, bacterial pathogens can have E3 ligase activity and 
these proteins are named as bacterial E3 ligase effectors (BELs) [79]. Varying pathogenic 
bacterium species that use Type III or Type IV secretion systems have BELs secreted through 
infection. Salmonella, Shigella, Chlamydia, Pseudomonas, and Legionella, all exploit 
ubiquitination machinery.  
There are two RING domain containing BEL proteins secreted by Legionella (Figure 1-2). 
GobX protein sequence shows similarities to other eukaryotic E3 enzymes and it is shown to 
localize at the Golgi when over-expressed in mammalian cells. Palmitoylation of GobX allows the 
enzyme to be localized on the membrane. The exact role of the enzyme during infection is not 
known, but it is speculated to be involved in the regulation of either vesicle traffic to the LCV or 
the blocking of the exocytosis pathway [80]. LubX E3 ligase is secreted at a later stage of infection 
and does not target host proteins. It acts as a meta-effector: a bacterial effector protein that acts on 
another effector protein from the same bacteria. SidH effector is shown to be ubiquitinated by 
LubX and sent to proteasome to regulate its function during infection [81]. LubX was also shown 
to interact with and ubiquitinate Cdc2-like kinase 1 that regulates alternative splicing by 
phosphorylating SR protein of splicing regulators [82]. The exact reason behind the possible 
splicesome  modulation by Legionella remains elusive because the infection can progress normally 
with lubX deletion from Legionella genome [83]. 
F-box motif containing proteins are involved in a slightly modified ubiquitination pattern. 
The proteins with F-box motif bind to Skp1; and Cul1 and this complex bind to RING-box 1 
(Rbx1) protein to form a fully functional E3 ligase [84]. Legionella is reported to secrete five 
effectors that have a predicted F-box motif. LegU1 (AnkB) and LegAU13 (Ceg27) are shown to 
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physically interact with Skp1 and Cul1 [85]. AnkB was shown to target the HAL-B associated 
transcript 3 protein Bag6 which is ER-localized and shown to be involved in various pathways 
including protein degradation, chaperone, and ER stress [86]. The target of LegAU13 protein was 
not identified, but the effector is shown to interact with other proteins by its ankyrin repeat domain 
[87] and the essentiality of the protein for infection is not conserved in all species. Interestingly, 
even though the reason is yet to be determined, the protein is shown to be farnesylated [88]. 
Another interesting E3 ligase secreted by Legionella is SidC (and its paralog SdcA). The protein 
is a typical BEL to “steal” the ubiquitin from E2s in the host (UbcH5) and transfer it to targets yet-
to-be-determined [59]. The protein is shown to have a PI(4)P binding domain (P4C) that targets 
the membrane on LCV and allosterically regulates the E3 activity by blocking the active site when 
not bound to the membrane [89].  
1.5 SidE Effector Protein Family 
 
 
 
 
 
 
 
Figure 1-3: SidE Protein Family. Legionella effectors SidE protein family consists of nine 
members. Large members, SidE, SdeA-C, contain a DUB domain, a PDE domain, a mART 
domain linked to a Mid domain and an uncharacterized C’-coiled coil domain. The small members 
share the PDE domain.  
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Legionella effector proteins are highly regulated during and after the host cell takeover. 
These effectors are either regulated by other effectors named as meta-effectors or by localizing to 
different parts of the cell during infection. For the latter strategy, Legionella has protein paralogs 
that are very similar but differ slightly in functionality. SidC and SdcA, as an example, are two E3 
ligases that share a high level of homology but can function with two different E2 enzymes [59]. 
There are also protein families that share domains among other functional domains. SidE protein 
family was first found to be expressed in the early stages of the infection and localized at the tip 
of the LCV [90] and even was predicted to be secreted before the phagocytosis of the bacterium 
[91]. The protein family consists of nine members: four large proteins and five smaller proteins. 
All these proteins share a phosphodiesterase (PDE) domain with previously unknown function 
(Figure 1-3). The first characterization work was for the N terminal region of the large SidE 
members. It was found that the N terminal region acts as a DUB enzyme and can cleave ubiquitin 
modification by K11, K48 or K63 linkages [92]. The actual interesting story about these proteins 
was reported by the following domains that the large members of the SidE family share. It was 
shown that these proteins can ubiquitinate targets independent of ubiquitin activation by an E1 and 
E2 enzyme-cascade. It was revealed that by using an NAD molecule as a cofactor, the mono ADP 
ribosyl-transferase (mART) domain ADP ribosylates ubiquitin molecule from its R42 residue [93]. 
The domain upstream of mART contains the shared PDE domain by the SidE members. PDE 
ligates the ADP-ribosylated ubiquitin to the target protein by cleaving the ADP-ribose moiety from 
the β-phosphate and linking the phosphate to the serine residue of the target protein and releasing 
an AMP molecule. This creates a phosphoribosyl ubiquitin moiety on the target protein (Figure 1-
4) [94]. 
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Figure 1-4: Phosphoribosyl-ubiquitination by SdeA. Schematic diagram of the phosphoribosyl 
ubiquitination reaction catalyzed by SdeA. First reaction is carried out by its mART domain and 
the second by its PDE domain. 
 
In two distinct studies, two proteins were shown to be targeted by SidE family: Rab33b [93] and 
Reticulon 4 [25]. The outcome of phosphoribosyl-ubiquitination of Rab33b is only speculated: the 
Rab GTPase is localized on Golgi and is involved in Golgi to ER trafficking and progression of 
autophagy by helping the localization of Atg12 protein on autophagosome membrane [95]. With 
this information, the authors claim the PR-ubiquitination of Rab33b might affect either Golgi to 
ER retrograde trafficking, or it might affect the autophagy pathway. Both pathways might help 
with the formation of LCV [93], but the fact that PR-ubiquitination of Rab33 does not affect its 
GTPase activity raises some questions [94]. The other target protein, Reticulon 4, is an ER 
membrane protein [96] and is shown to generate ER membrane curvature by inserting hydrophobic 
hairpin structures into the cytoplasmic site of ER [97]. Reticulon 4 is shown to be localized to LCV 
during infection and after the PR-ubiquitination of this protein, it is shown to “pull” ER tubules to 
cover the LCV [25]. The only other study about this protein family shows lpg1496 to have an 
additional KLAMP domain that interacts with cyclic nucleotides [98].  
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1.6 Conclusion 
Legionella pneumophila is a pathogen that invades alveolar macrophages and causes 
Legionnaires’ disease. The completion of the host cell invasion relies on the formation of LCV by 
the bacteria. LCV formation requires a highly regulated secretion and functioning of Legionella 
effector proteins. These proteins affect host pathways including protein expression, lipid 
metabolism, protein-lipid signaling, protein degradation, and autophagy. Like other pathogens, 
Legionella secretes proteins that contain eukaryotic protein domains and can alter host pathways 
that prokaryotes normally do not have. One of the eukaryotic pathways that Legionella disrupts is 
ubiquitination. There are E3 ligases secreted to steal ubiquitin from the corresponding E2 enzymes 
that help with the formation of the LCV. Recently, it was shown that SidE proteins modify 
ubiquitin in a unique phosphoribosylation mechanism and labels target proteins with this unusual 
phosphoribosyl-ubiquitin moiety.  
The significance of SidE family proteins lies in the phosphoribosylation reaction. The PDE 
domain of SidE family is significant for being the first documented PDE domain to act on proteins 
instead of nucleic acids or lipids. The coordination of an mART domain with a PDE domain is 
documented for the first time as well. For other ADP Ribosylation domains, the ligated moiety is 
hydrolyzed from the protein directly without cleaving any part of the ADP moiety in a reversible 
way, just as in the example of Poly (ADP-ribose) polymerase enzymes (PARPs) [99]. These 
proteins are involved in DNA repair and synthesis processes and can poly or mono-ADP-ribosylate 
proteins. [100]. The PDE domain of SidE family differs by cleaving the AMP from the ADP-ribose 
moiety to irreversibly modify ubiquitin before ligating it to a target protein. There are currently no 
documented eukaryotic PDE domains that can cleave AMP from an ADP-ribose moiety. How 
Legionella acquired this specific PDE activity remains elusive. Rab33b and Reticulon 4 proteins 
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are shown to be targeted by SidE proteins. The modification during infection is shown by different 
studies, but why these proteins are targeted during infection also remains elusive. It is important 
to know why Legionella is targeting host proteins in a unique way, especially because the 
modification of Rab33b doesn’t inhibit or increase its GTPase activity [101].  
There are currently 324 known effector proteins secreted during infection and 
approximately one-third of these proteins have documented functions or roles during infection. 
The arsenal of Legionella remains elusive and new pathways that these proteins are involved in 
need to be solved to completely understand and map the infection submersion by Legionella. This 
knowledge will help to understand the infection of other pathogens as well.  
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CHAPTER 2 
 
THE MOLECULAR MECHANISM OF LEGIONELLA EFFECTOR-MEDIATED 
PHOSPHORIBOSYl-UBIQUITINATION 
 
2.1 Abstract 
Ubiquitination is a post-translational modification that regulates a myriad of cellular 
processes in eukaryotes[1-4]. The conventional ubiquitination cascade culminates in a covalent 
linkage between the C-terminus of ubiquitin (Ub) and a target protein, most often on a lysine 
sidechain[1, 5]. Recent studies of the Legionella pneumophila SidE family of effector proteins 
have revealed a novel mode of ubiquitination in which a phosphoribosylated ubiquitin (PR-Ub) is 
conjugated to a serine residue of substrates via a phosphodiester bond[6-8]. To uncover the 
molecular mechanism of this unique post-translational modification, we determined the crystal 
structure of a fragment of a SidE family member SdeA that retains its full ubiquitination activity. 
The structure reveals that the catalytic module contains three distinct domains: a phosphodiesterase 
domain (PDE), a middle α-helical domain (Mid) of unknown function, and a mono-ADP-
ribosyltransferase (mART) domain. Biochemical analysis shows that the Mid domain is 
indispensable for mART domain-mediated ADP-ribosylation of Ub and presumably plays a role 
in Ub recognition. Our data also demonstrate that the conversion of Ub to ADP-ribosylated Ub 
(ADPR-Ub) and the ligation of PR-Ub to substrates are two independent activities of SdeA. 
Finally, we present two crystal structures of a homologous PDE domain from the SidE family 
member SdeD[9] in complex with Ub or ADPR-Ub, which reveal an intriguing mechanism for 
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how SdeA processes ADPR-Ub to PR-Ub and AMP and conjugates PR-Ub to a serine residue of 
substrates. Therefore, our results establish the molecular mechanism of phosphoribosyl-
ubiquitination (PR-ubiquitination) and pave the way for future studies of this unusual type of 
ubiquitination in eukaryotes. 
2.2 Introduction 
Posttranslational protein modification by ubiquitin (Ub) is a central eukaryotic mechanism 
that regulates a plethora of physiological processes, including protein homeostasis [1], cell 
signaling [2], and membrane trafficking [3, 4]. Following the conventional scheme of 
ubiquitination, Ub is covalently coupled to lysine residues on target proteins via the sequential 
activities of a collection of enzymes known as E1, E2, and E3 [10]. The C-terminal glycine residue 
of Ub is first activated and covalently linked to the catalytic cysteine residue of the Ub activating 
enzyme E1 through a thioester bond with the consumption of an ATP. The activated Ub moiety is 
then transferred to the active site cysteine of an E2 Ub-conjugation enzyme. The resulting 
thioester-linked E2~Ub complex interacts with specific E3 Ub ligases, which promote the direct 
or indirect transfer of Ub to either the ε-amine of a lysine residue targeted proteins or the N-
terminal amine of another Ub [11-13]. 
Given the vital role of ubiquitination in cell physiology, it is not surprising that a variety 
of microbial pathogens exploit this essential posttranslational modification pathway during the 
infection of their corresponding hosts [14]. For example, among the hundreds of effectors injected 
into host cells by the Dot/Icm transporter of the intracellular pathogen L. pneumophila, more than 
10 proteins are involved in ubiquitin manipulation [15] including  those that contain conserved 
eukaryotic F- or U-box domains found in E3 ubiquitin ligases [16-19]. Other E3 Ub ligases that 
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have a unique structural fold but similar catalytic chemistry to the HECT-type ligases have also 
been characterized [20, 21]. In addition to these Ub ligases which utilize the canonical  
Figure 2-1: Schematic Diagram of the 
Enzymatic Pathway Catalyzed by SdeA. 
Serine ubiquitination catalyzed by SdeA 
involves two activities. First, the mART activity 
facilitates the ADP-ribosylation of Ub to 
generate ADPR-Ub by consuming an NAD+. 
Second, the PDE activity catalyzes the cleavage 
of ADPR-Ub to PR-Ub if a water molecule is the 
Ub acceptor or the conjugation of PR-Ub to 
serine residues of substrate proteins if a substrate 
is present 
 
host Ub machinery for ubiquitination, recent studies of the L. pneumophila Sde family effectors, 
such as SdeA uncovered a novel ubiquitination pathway that acts independently of E1 and E2 
enzymes [6-8]. Instead, this unusual SdeA-catalyzed ubiquitination involves both mono-ADP-
ribosyl transferase (mART) and phosphodiesterase (PDE) activities. SdeA first catalyzes the 
transfer of ADP-ribose from NAD+ to the arginine 42 of ubiquitin to generate mono-ADP-
ribosylated Ub (ADPR-Ub), using its mART activity. Subsequently, via the activity of the PDE 
domain, ADPR-Ub is transferred to a water molecule to generate phosphoribosylated ubiquitin 
(PR-Ub) and releases AMP in the absence of substrate proteins. Alternatively, ADPR-Ub can be 
conjugated to serine residues of substrate proteins to generate serine ubiquitinated products (Figure 
2-1). Unlike conventional ubiquitination, this process is ATP independent. Instead, it consumes an 
NAD molecule in the activation of a Ub molecule. Moreover, there is no detectable difference in 
substrate ubiquitination when Ub mutants either carries substitutions on all surface lysine residues 
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or lacks the C-terminal di-glycine residues. Although the reaction products and the chemical 
linkage of SdeA-mediated ubiquitination have been established [6-8], the molecular mechanism 
of this unique ubiquitination pathway remains elusive, for example: how Ub is specifically 
recognized and modified by SdeA; how ADPR-Ub is processed and conjugated to substrates; and 
whether the intermediate ADPR-Ub generated by the mART is channeled to the PDE domain for 
the subsequent ligation to substrates. Detailed structural and biochemical studies are warranted to 
address these intriguing questions.  
 We have determined the crystal structure of a portion of SdeA (a.a. 211-910) that contains 
the predicted mART and PDE domains and is fully functional in catalyzing ubiquitination. Our 
structure reveals that the mART and PDE domains are packed tightly against each other, but the 
active sites of these two domains face opposite directions and are separated by a long distance. 
This structural organization corroborated with our biochemical results indicates that the ADP-
ribosylation of Ub and the conjugation of ADPR-Ub to substrates are functionally independent. 
Our structure also unveils another conserved domain that is connected to the core of the enzyme 
via two long flexible loops. We show evidence that this domain may function to recruit and present 
Ub molecules to the mART domain for ADP-ribosylation. We have further determined the crystal 
structures of a homologous PDE domain from another Legionella effector SdeD [9] in its apo form 
and in complex with both Ub and ADPR-Ub. These structures show that Ub binds to the PDE 
domain and buries a large interface between the two molecules. More importantly, this interaction 
allows the ADPR moiety from ADPR-Ub to be positioned snugly in the deep catalytic groove of 
the PDE domain. Insights from our structural studies, together with biochemical and infection 
analysis, reveal an intriguing molecular mechanism underlying this unprecedented ubiquitination 
cascade.  
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2.3 RESULTS 
Overall Structure of SdeA 
It has been shown that substrate modification by PR-Ub is mediated by a portion of SdeA 
(a.a. 205-1000) that contains a predicted phosphodiesterase (PDE) and mono-ADP-
ribosyltransferase (mART) domain [6, 7]. To probe the molecular mechanism of this unusual type 
of ubiquitination, we determined the crystal structure of SdeA (a.a. 221-910) by single-wavelength 
anomalous dispersion (SAD) phasing of crystals soaked with HgCl2. The structure is comprised 
of three distinct domains, the PDE, mART, and an alpha-helical domain with unknown function 
(Figure 2-2).  
The PDE domain mainly consists of alpha helices.  The active site resides in a deep groove 
lined with mostly conserved residues, particularly the two invariant histidines. There is no 
significantly charged area on the surface of SdeA except for the PDE active site, which is highly 
positively charged (Figure 2-2 C and D). The concentrated positive charge at the PDE active site 
may facilitate the positioning of the phosphate groups of its substrate, ADPR-Ub. The overall 
structure of the SdeA PDE domain has a similar fold to that of another Legionella effector lpg1496 
[22] with a root mean square deviation (rmsd) of 1.9 Å over 225 aligned Cα atoms. A prominent 
difference between the PDE domains is that the loops connecting the alpha helices vary both in 
primary sequence and in length (see Figure 2-8). Since these loops are protruding along the side 
of the active site groove, it is tempting to postulate that these loops may interact with targeted 
substrate proteins and play a role in substrate selection. 
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Figure 2-2: Overall Structure of SdeA. (A) Ribbon diagram of the overall structure of SdeA 
(211-901). This portion of SdeA has three distinct domains, including the PDE (shown in green), 
Mid (cyan), and mART (gold) domains. The active site residues of both the mART and PDE 
domains are shown in red spheres. The linear distance between these two active sites is about 55 
Å. (B) An orthogonal view of (A). (C) Molecular surface of SdeA. The surface is colored based 
on electrostatic potential with positively charged regions in blue (+4 kcal/electron) and negatively 
charged surfaces in red (-4 kcal/electron). The orientation of the molecule is the same as shown in 
(A). (D) A 90o rotated view of (C). The active site of the PDE domain is highly positively charged, 
which may facilitate the docking of the ADPR pyrophosphate group. 
 
The mART domain of SdeA is composed of two nearly perpendicular β sheets. This two-
layered β-sandwich core is flanked by three alpha helices bridging between the β strands. A 
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structural homology search with the Dali server [23] yielded a list of hits including the 
Pseudomonas syringe type III effector HopU1 (PDB ID: 3u0j) and the Clostridium perfringens 
toxin Iota-toxin (PDB ID 4H03). Both HopU1 and Iota-toxin are mono-ADP-ribosyltransferase 
that specifically modify the glycine-rich RNA-binding protein GRP7 [24] and actin [25] from the 
hosts, respectively. A structural comparison showed that the β-sandwich core is similar among all 
three of the mART proteins (Figure 2-3). All three mART proteins have three catalytically 
important conserved motifs: the (F/Y)-(R/H), STS, and EXE motif, suggesting a similar catalytic 
mechanism for ADP-ribosylation. However, the mART domain of SdeA displays two major 
differences compared to that of HopU1 and Iota-toxin. First, the ADP-ribosylating turn-turn loop 
(ARTT), which contains the EXE motif and is important for target protein recognition, is variable 
in sequence and highly flexible in conformation. Second, both HopU1 and Iota-toxin contain an 
additional alpha helical region at their N-terminus (colored in gray in Figure 2-3 b), which has 
been shown to be essential for substrate protein binding [24, 25]. However, the mART domain of 
SdeA lacks such an alpha helical portion. These two major structural differences suggest that the 
mART domain of SdeA may use a distinct mechanism to recognize its specific substrate, Ub.  
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Figure 2-3: Structural Comparison of the mART Domain with Other mART Domains from 
Bacterial Toxins. (A) Ribbon diagram model of the mART domain of SdeA. (B) Ribbon diagram 
of HopU1 from Pseudomonas syringe (PDB ID: 3u0j). (C) Structural superimposition of the 
mART domains from SdeA (gold) and HopU1 (blue). (D) Ribbon diagram of Iota-toxin from 
Clostridium perfringens (PDB ID 4H03) and (E) Iota-toxin in complex with NAD (red spheres). 
(F) Structural overlay of the mART domains from SdeA (gold) and Iota-toxin (cyan). Residues 
comprising the catalytically important (F/Y)-(R/H), STS, and EXE motifs are shown in sticks and 
ARTT loop is indicated by a dash-lined circle. Note the structural core of the three mART domains 
have a similar fold, however, both HopU1 and Iota-toxin have additional alpha helical regions 
(colored in gray) while the mART domain of SdeA lacks such an equivalent structural component.  
 
In addition to the PDE and mART domains, a third domain (a.a. 593-752), which we named 
the Mid domain, resides between the PDE and mART domains (Figure 2-2). The Mid domain 
contains 8 alpha helices of variable length. Interestingly, the longest alpha helix occupies the center 
of the domain forming a central axis around which the other 7 shorter alpha helices pack with 
different orientations (Figure 2-2 A and B). A structural homology search with the Dali server 
using the Mid domain yielded no hit above the threshold of meaningful similarity. A primary 
sequence analysis revealed that the Mid domain is only found in SdeA-related proteins upstream 
of the mART domain. These observations suggest that the Mid domain may have a unique function 
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relevant to the mART activity. Moreover, the Mid domain is connected to the core of the protein 
through two long flexible peptides (Figure 2-2). The observed conformation of the Mid domain 
relative to the rest of the protein is likely due to contacts in crystal packing. The flexibility of the 
Mid domain indicates that it can “communicate” with the rest of the protein by assuming different 
conformations.  As discussed above, just as the mART domains of HopU1 and Iota-toxin have an 
N-terminal alpha-helical region that mediates substrate recognition, it is plausible that the Mid 
domain may function to recruit specific substrates for SdeA. 
The Mid Domain of SdeA is Indispensable for ADP-ribosylation of Ub 
We have shown that the Mid domain is required for the ADP-ribosylation of Ub. An 
intriguing question emerges as to how the Mid domain contributes to the modification of Ub. As 
proposed above, the Mid domain may function to recruit and present Ub to the mART domain, 
similar to the alpha helical regions found in other mART proteins. We first analyzed the sequence 
conservation of SdeA with the ConSurf server [26]. It is striking to note that the primary sequence 
of the Mid domain is highly conserved and that the most conserved residues form a prominent 
surface patch containing residues N723, Q727, and R729 (Figure 2-4 A). To further analyze the 
functional role of this conserved surface patch, we created single alanine mutations of these 
residues, as well as a nearby non-conserved F719 and a conserved residue D622 away from the 
patch. We also created an SdeA truncation with the entire Mid domain removed (Mid), and then 
assayed these proteins for enzymatic activity. As expected, Mid showed no activity in modifying 
Ub (Figure 2-4 B) while D622A displayed an activity level comparable to wild type SdeA. The 
F719A mutant, which is not conserved but is close to the conserved surface patch showed a 
significant impairment in producing ADPR-Ub. Strikingly, Ub ADP-ribosylation activity was 
completely abolished in SdeA carrying either of the N723A, Q727A, or R729A mutations. All the 
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aforementioned mutant proteins have similar expression levels and size-exclusion 
chromatographic behaviors comparable to wild type SdeA (Figure 2-4 C) and their PDE domains 
are fully functional in the conversion of ADPR-Ub to PR-Ub.  
 
Figure 2-4: The Mid Domain of SdeA Is Indispensable for Ub ADP-ribosylation. (A) 
Sequence conservation of SdeA using a molecular surface representation (the most conserved 
residues are in purple and the least conserved residues in cyan). Sequence conservation is 
calculated by the ConSurf server (consurf.tau.ac.il). A zoomed-in view of a surface cluster 
comprised of the most conserved residues on the Mid domain. (B) Quantitative analysis of in vitro 
ubiquitin modification assays by SdeD mutants carrying mutations at its middle domain. The 
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reaction products were analyzed by native-PAGE and stained with Coomassie (top panel) and Pro-
Q phosphoprotein stain (lower panel). (C) SDS-PAGE analysis of the proteins in the reaction 
mixture. 
 
Taken together, our data show that the Mid domain is indispensable for the Ub ADP-
ribosylation activity, and a surface patch which comprises of highly conserved residues on the Mid 
domain is crucial for this activity.  
ADP-ribosylation of Ub and Serine Ubiquitination Are Two Independent Activities of SdeA 
Our structure of SdeA revealed that the PDE and mART domains are packed against each 
other (Figure 2-2).  It is worth noting that the catalytic sites of the PDE and mART domains are 
facing opposite directions with a straight linear distance of more than 55 Å between them. The 
geometric separation of these two catalytic sites raises an interesting question: How is the product 
from the mART, ADPR-Ub, loaded to the catalytic site of the PDE domain? 
To address whether the catalytic activities of the mART and PDE domains are coordinated, 
we first set out to define the minimum region on SdeA that can ADP-ribosylate Ub. We generated 
a series of SdeA truncations and analyzed their ADP-ribosylation activity. Wild type SdeA 
spanning residues 211 to 910 efficiently modified Ub, as visualized on a native- PAGE gel (Figure 
2-5). SdeA (563-910), which contains the last alpha helix (designated as αT) from the PDE domain, 
the Mid, and mART domains, could also modify Ub. However, SdeA (592-910), which spans the 
entire Mid and mART domains, was completely inactive, as was the mART domain alone (a.a. 
752-910). These results demonstrate that both αT and the Mid domain are indispensable for ADP-
ribosylation of Ub. The C-terminal portion of αT is enriched with hydrophobic residues and forms 
intensive hydrophobic and Van der Waals interactions with a hydrophobic patch on the outer 
surface of the mART β-sandwich core (Figure 2-5 A). It is possible that αT helps with structural 
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stability of the mART domain. However, it is also possible that αT provides a stable anchor point 
for the Mid domain, which can facilitate proper domain motions that may be required during the 
Ub ADP-ribosylation reaction (discussed below). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-5: Mapping the Minimum Functional Region on SdeA Containing the mART 
Activity. (A) Ribbon diagram of minimum region that retains the ADP-ribosylation activity. This 
minimum region contains the last alpha helix (αT) from the PDE domain and the entire Mid and 
mART domain. αT packs against one side of the β sandwich of the mART domain though intensive 
hydrophobic interactions (zoomed-in view). Spheres labeled with residue numbers mark the 
boundary of constructs used for ADP-ribosylation activity assays. (B) ADP-ribosylation assays of 
Ub with indicated SdeA proteins. The reaction products were examined by native-PAGE.  
 
We next set out to test whether the activities of the mART and PDE domains are 
interlinked. SdeA (211-910) was shown to convert Ub to ADPR-Ub and subsequently to PR-Ub, 
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as visualized both on the native-PAGE gel (the band labeled with modified Ub) and 
phosphoprotein specific Pro-Q Diamond stain due to the exposed phosphoryl group on PR-Ub 
[27]. In contrast, a SdeA (211-910) H227A mutant, which retains the ability to generate ADPR-
Ub, is defective in processing ADPR-Ub to PR-Ub. Consequently, Ub band-shift caused by this 
mutant was evidently on the native-PAGE gel but no PR-Ub signal could be detected with the Pro-
Q stain (Figure 2-6 B). Parallel reactions in which both SdeA (211-910) H227A and SdeA (211-
592) (containing only the PDE domain) were added successfully converted Ub to PR-Ub. 
Similarly, reactions containing both SdeA (211-592) and SdeA (563-910) were also competent to 
generate PR-Ub. This data suggests that the conversion of Ub to PR-Ub can be achieved even 
when the mART and PDE activities are in two separated peptides. The independence of these two 
activities was further confirmed by SdeA-mediated ubiquitination of a substrate, Rab33b [6]. We 
observed that Rab33b was ubiquitinated to a similar extent compared to wild type SdeA when the 
PDE and mART activities were in two separate peptides (Figure 2-6 C). Interestingly, the SdeA 
PDE domain alone was able to ubiquitinate Rab33b comparable to wild type SdeA in the presence 
of purified ADPR-Ub (Figure 2-6 D). This data demonstrates that the PDE domain can use freely 
diffusing ADPR-Ub to ubiquitinate its substrates. To validate the independence of the two 
activities in vivo, we co-transfected Flag-tagged Rab33b and GFP-tagged SdeA constructs in HEK 
293T cells. Ubiquitination of Rab33b was observed when plasmids expressing the PDE (211-592) 
and the portion containing the mART activity (563-910) were co-transfected (Figure 2-6 E). These 
results further support our conclusion that ADP-ribosylation of Ub and serine phosphoribosylated 
ubiquitination are two mechanistically independent activities. 
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Figure 2-6: Phosphoribosylation of Ub and Serine Ubiquitination Are Two Independent 
Activities of SdeA. (A) Schematic diagram of the domain structure of SdeA. Some of the Sde 
family proteins are comprised of an N-terminal de-ubiquitinase (DUB) domain (gray), followed 
by a PDE (green), Mid (cyan), mART (gold), and a C-terminal coilded-coil (CC) domains (gray). 
(B) In vitro Ub-modification assays. Indicated SdeA proteins were mixed with Ub in the presence 
or absence of NAD. The modification of Ub to ADPR-Ub or PR-Ub can be monitored by the 
indicate band shift of Ub in native-PAGE (top panel). The production of PR-Ub can be visualized 
by phosphoprotein staining with Pro-Q Diamond stain (middle panel). All the proteins in the 
reaction mixtures were subjected to SDS-PAGE and visualized by Coomassie staining (lower 
panel). (C) In vitro ubiquitination assay of Rab33b by indicated SdeA proteins. Each reaction 
condition was the same as the corresponding lane in (B) except for the addition of recombinant 
Flag-tagged Rab33b. The reaction products were analyzed by anti-Flag Western-blot. (D) In vitro 
ubiquitination assay of Rab33b in the presence of purified ADPR-Ub. The reactions were 
performed with indicated SdeA proteins, Flag-Rab33b, and purified ADPR-Ub. The ubiquitination 
of Rab33b was analyzed by anti-Flag Western-blot. (E) In vivo ubiquitination assays of Rab33b 
by SdeA. Constructs expressing Flag-Rab33b, GFP or indicated GFP-tagged SdeA were co-
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transfected in NIH HEK293T cells. Whole cell lysates were subjected to immunoprecipitation with 
Flag beads and the products were probed with anti-Flag Western-blot (top panel). The expression 
of GFP-SdeA constructs were analyzed by anti-GFP Western-blot (Bottom panel). 
 
Ub Recognition by the PDE Domain  
We have shown that the isolated PDE domain of SdeA was able to process ADPR-Ub to 
PR-Ub and ubiquitinate its substrate proteins (Figure 2-6). This PDE domain has 23% sequence 
similarity to its counterpart in Pseudomonas aeruginosa PA4781, a well-characterized cyclic di-
3’,5’-GMP phosphodiesterase [28].  This lead us to ask how the PDE domain of SdeA can catalyze 
such a highly unusual reaction. To address this question, we first tested the interaction of Ub and 
several homologous PDE domains from the Legionella SidE family effectors using 1H, 15N-HSQC-
TROSY NMR titration experiments (Figure 2-7). The PDE domain of SdeA showed no detectable 
interaction with Ub, while the PDE domain of another SidE family member, SdeD displayed 
tighter interaction with Ub. SdeD was originally categorized as a member of the Sde family due to 
its high sequence homology in the PDE domain [9].  
 
Figure 2-7: NMR titration analyses of the interaction between Ub and the PDE domains of 
SdeA and SdeD. (A) Spectral overlay of 150uM Ub (black) in the absence or presence of 300uM 
SdeA PDE (cyan) Ub binds weakly to SdeA as manifested by minimum changes of H-N peaks of 
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Ub. (B) Spectral overlay of 150uM Ub (black) with 75uM SdeD PDE. Ub binds much tighter to 
SdeD resulting in peak broadening and disappearance of resonances. (C) The most effected 
resonances in the presence of SdeD are mapped in red on a ribbon structure of Ub. 
 
Through extensive crystallization trials, we succeeded in obtaining crystals of the PDE 
domain of SdeD both by itself and in complex with Ub.. The structure of the apo SdeD PDE 
domain was solved by selenomethionine SAD phasing. The overall structure of the SdeD PDE is 
very similar to that of SdeA with an rmsd of 1.73 Å over 251 overlaid Cα atoms.  However, a 
major difference between SdeA and SdeD, similar to that between SdeA and lpg1496, resides on 
the size and position of the loops connecting the alpha helices (indicated with dashed-circles, 
Figure 2-8). Nevertheless, in all the PDE domains, the active site, containing the most conserved 
residues including two catalytic histidines, is located in a deep V-shaped groove. The groove is 
open at one end to a large and rather flat surface, which is nearly perpendicular to the groove 
(Figure 2-8).  
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Figure 2-8: Overall Structure of the PDE Domain of SdeD and its Comparison with the PDE 
Domain of SdeA. (A) Ribbon model of the PDE domain of SdeD (gray). Two catalytic histidine 
residues shown in sticks (cyan) (B) The PDE Domain structure of SdeA. (C) Structural overlay of 
these two PDE domains. The variability unique to each PDE domain is indicated by a dash-lined 
circle. (D) Surface representative of the PDE domain of SdeD. The catalytic histidines are located 
at the bottom of a deep V-shaped groove. (E) Surface representative of the PDE domain of SdeA. 
(F) Surface residue conservation analysis of the PDE domain. The most conserved residues are 
colored in purple and the least conserved residues are in cyan.  
 
We also solved the structure of the SdeD PDE domain in complex with Ub. To our surprise, 
we observed two Ub binding sites on the SdeD PDE domain.  The first Ub (Ub1) binds on the 
aforementioned flat surface at the opening of the groove (Figure 2-9). A total of 1374 Å2 surface 
area is buried at the Ub1 and SdeD interface. Three major regions of Ub1 are involved in the 
binding, including the loop region around T9 (T9 loop), the C-terminal end, and the vicinity of 
R42. At the T9 loop, L8 and the methyl group of T9 form hydrophobic interactions with SdeD 
while the T9 hydroxyl group and K6 form hydrogen bonds and electrostatic interactions with 
corresponding residues on SdeD (Figure 2-9 A). The C-terminus of Ub1 is also extensively 
engaged in the binding, which includes hydrophobic interactions mediated by L73, hydrogen 
bonding and electrostatic interactions contributed by R72 and the carboxyl terminus of G76 
(Figure 2-9 A). The third interacting region on Ub1 involves the residues in the vicinity of R42. 
Most strikingly, the R42 sidechain of Ub1 sticks into the groove and forms hydrogen bonds and 
electrostatic interactions with the conserved residues Q52 and E126 at the catalytic site. It is very 
likely that the binding between Ub1 and SdeD represents the physiological interaction between Ub 
and the PDE domain of SdeA/SdeD. With this mode of binding, the ADPR moiety would be 
positioned into the groove ready for the reaction at the catalytic site. Ub1 buries a large surface 
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area on the PDE domain (Figure 2-9 A). This surface area is rather flat and nearly perpendicular 
to catalytic groove. Although the overall shape of this surface is also preserved in the PDE domain 
of SdeA (Figure 2-8 E), residues comprise this surface area are not well conserved (Figure 2.8 F). 
The large number of residues involved in close contact with Ub and the sequence variability of 
those contact sites hampered our attempts to design point mutations to dissect the roles of these 
residues on Ub binding. We thus focused on key Ub to investigate the recognition of Ub by the 
PDE domain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E 
E 
E 
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Figure 2-9: The Interaction of Ub with the PDE Domain of SdeD. (A) Overall complex 
structure of Ub (Ub1) with the PDE domain of SdeD. Ub1 is shown in cyan-colored ribbon. The 
PDE domain is shown in gray surface. The area that is within in the Van-der Waals distance range 
to Ub1 is colored in light blue. Ub1 binds at the opening of the PDE catalytic groove. Three major 
regions on Ub1 involved in the interaction with the PDE domain are marked by dash-lined squares. 
(B) A zoomed-in view of the T9-loop region of Ub1 interacting with the PDE domain. (C) A 
zoomed-in view of the C-terminus of Ub1 at the interface with the PDE domain. (D) A close view 
of the region near the Ub1 R42. The sidechain of the R42 of Ub1 sticks into the catalytic groove 
and forms hydrogen bonds and salt bridges with Q52 and E126. Conserved residues lining in the 
catalytic groove are shown in sticks. (E) The PDE domain of SdeD is bound with two Ub molecules 
Ub1 (cyan) and Ub2 (blue). Ub1 binds at the opening of the PDE catalytic groove with its R42 
sidechain sticking into the groove. Ub2 binds a region on the opposite side of the PDE domain. 
(F) Structural superimposition of the complex structure with the structure of SdeA referenced on 
the PDE domain 
 
The second Ub (Ub2) binds on the opposite side of SdeD (Figure 2-9 E) and occludes an 
area of 764 Å2 at the interface. The physiological significance of this binding site is not clear. This 
binding site certainly does not exist in SdeA, as it would collide with the mART domain (Figure 
2-9 F). It is interesting to note that the interaction between Ub2 and SdeD is also mediated mainly 
by the T9 loop and the carboxyl terminus of Ub2. A structural comparison of Ub1 and Ub2 
revealed that the conformation of all the residues is nearly identical except for the T9 loop and the 
carboxyl terminus. These observations suggest that the conformational flexibility of the T9 loop 
and the carboxyl terminus bestows Ub with the versatility to interact with totally different protein 
surfaces using the same group of residues.  
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ADPR-Ub Binding to the Active Site of PDE 
Our complex structure of SdeD with Ub revealed the mode of interaction between Ub and 
the PDE domain of SdeD, but how exactly the ADPR moiety fits in the groove remained elusive. 
To address this question, we sought to determine the complex structure of the SdeD (H67A) mutant 
with ADPR-Ub (generated by reacting Ub and NAD with mutant SdeA retaining the mART but 
not the PDE activity). Although we obtained crystals containing SdeD and ADPR-Ub, those 
crystals were of poor quality. We reasoned that the ADPR moiety in Ub2 may disrupt the crystal 
packing with adjacent molecules (Figures 2-9 E). We then tried to crystalize the SdeD PDE domain 
with 2:3 molar ratio of ADPR-Ub and Ub. We expected that ADPR-Ub would have a higher 
affinity for binding at the Ub1 site while wild type Ub would preferentially bind to the Ub2 site 
due to crystal packing contacts. Indeed, we obtained crystals with good diffraction quality using 
this strategy, and it was gratifying to observe that ADPR-Ub bound at the Ub1 site and wild type 
Ub bound at the Ub2 site.  
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Figure 2-10: Overall Structure of the PDE 
Domain of SdeD in Complex with ADPR-Ub 
and Ub. (A) The PDE domain of SdeD is bound 
with both ADPR-Ub (cyan) and wild type Ub 
(Ub2 in blue). ADPR-Ub binds at the opening of 
the PDE catalytic groove with the ADPR moiety 
fitting in the catalytic groove. Ub2 binds a region 
identical to the Ub2 found in SdeD-Ub complex. 
(B) Surface representation of the complex 
structure shown in (A). Note that the ADPR-
moiety shown in light green surface fits deeply in 
the catalytic groove. 
 
 
 
ADPR-Ub engages a similar mode of binding as Ub1 with the SdeD PDE domain. The 
ADPR moiety extends into the large catalytic groove and resides on top of the two catalytic 
histidine residues, which are lined at the bottom of the groove (Figure 2-11 A and B). The adenine 
ring of the ADPR moiety is sandwiched between the hydrophobic sidechains of M190 and F176. 
The hydroxyl groups of the two pentose moieties form hydrogen bonds with K197, H186, and 
Y119. Two arginine residues, R123 and R195, accommodate the β phosphate group by forming 
salt bridges (Figure 2-11 C).  Although the PDE domain in this complex carries the H67A 
mutation, based on the PDE-Ub complex structure, we can easily model back in the histidine in 
silico.  Presumably, H67 would assume a similar conformation as seen in the PDE-Ub complex 
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and it, together with other key catalytic residues E126 and H189, is lined at the bottom of the 
groove within attacking distance to the β phosphate group of ADPR.  
 
Figure 2-11: Complex Structure of ADPR-Ub with the PDE Domain of SdeD. (A) Surface 
representation of ADPR-Ub (cyan) in complex with the SdeD PDE domain (gray). The catalytic 
histidine residues (H67, H189) are colored in red. The ADPR moiety is shown in sticks and colored 
in light green. (B) Same view of the complex structure as in (A). The ADPR moiety is represented 
as a light green surface. Note that the catalytic site is completely sequestered from the bulk solvent 
when ADPR-Ub is docked. (C) A detailed interaction of the ADPR moiety within the catalytic 
groove of the PDE domain. Residues of the SdeD PDE domain that are involved in binding of the 
ADPR moiety are labeled and the corresponding residues in SdeA are labeled with parenthesis. 
Hydrogen bonds between ADPR-Ub and the PDE domain are specified by dashed yellow lines. 
The hydrophobic stacking of the adenine is depicted by dots. (D) Enzymatic activity analysis of 
conserved residues within the catalytic groove. All the procedures of the assay were like those 
described in Figure 2-6. (E) Rab33b ubiquitination assays by SdeA mutants carrying mutations on 
conserved residues within the catalytic groove.  
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Due to the structural similarity between the two PDE domains from SdeD and SdeA, we 
can easily model the binding of ADPR-Ub to the PDE domain of SdeA. Most of the residues in 
the catalytic groove that interact with ADPR are identical or functionally conserved between SdeD 
and SdeA. To test the role of the ADPR-interacting residues within the catalytic groove, we 
mutated several of those conserved residues in SdeA. Recombinant proteins (all containing 
residues 211-910) of the mutants were purified and their ability to modify Ub was analyzed (Figure 
2-11 D and E). The PDE activity was completely abolished in the H227A, H407A, and E340A 
mutants as indicated by the lack of the Pro-Q phosphoprotein staining signal. However, the mART 
activity of these mutants was in intact as indicated by the Ub band-shift in native gels (Figure 2-
11 D). In agreement with the defective PDE activity, these three mutants all failed to ubiquitinate 
Rab33b (Figure 2-11 E). The W394A mutant showed similar activity to wild type, suggesting the 
hydrophobic stacking of the adenine ring is not as critical. H281, which is completely invariable 
and is located near the β phosphate of ADPR, showed no obvious effect on activity when mutated 
to alanine. Conversely, the activity of R413A was significantly impaired, indicating the importance 
of proper positioning of the β phosphate for the reaction.  
 
2.4 DISCUSSION 
SdeD ADPR-Ub complex structure reveals that the large ADPR moiety occupies the entire 
catalytic groove and completely covers the three-essential catalytic resides E340, H277, and H281 
and shields them from the bulk solvents (For simplicity, we only use the residue numbering in 
SdeA. Figure 2-11 a-c). This ADPR-Ub enzyme binding mode prohibits potential direct contacts 
of Ub acceptor substrates with the catalytic residues for activation. This observation suggests that 
the ubiquitination reaction must be initiated without the participation of Ub acceptor substrates. 
Based on our structural and biochemical analysis, we propose that the conjugation of PR-Ub to 
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serine residues of substrate proteins is a two-step reaction (Figure 2-12). In the first step, the ADPR 
moiety is nestled in the catalytic groove upon the binding of ADPR-Ub to the PDE domain of 
SdeA. The negatively charged E340 stabilizes R42 from ADPR-Ub and also forms hydrogen 
bonds with H277. Thus, E340 increases the pKa of H277 and renders H277 a stronger nucleophile. 
H227 attacks the β phosphate of ADPR and forms a transient covalent phosphor-histidine linkage. 
The nearby H407 functions as a general acid to donate a proton to the α phosphate of the releasing 
AMP molecule. As a consequence of this step, a transient PR-Ub-enzyme complex is formed via 
a mechanism similar to the that of histidine phosphorylation, which is well established as a critical 
component of cell signaling and metabolism in prokaryotes [29]. Enzymes, such as the two-
component system histidine protein kinase, form a transient phosphor-histidine intermediate 
during the reaction [30]. In the second step, H407 deprotonates the hydroxyl of a serine residue of 
the approaching substrate. The activated hydroxyl then replaces H277 in the transient PR-Ub-
enzyme intermediate by attacking the phosphoryl group to form a stable phosphor-serine linkage 
between the substrate protein and PR-UB. In the final stage of the reaction, E340 functions as a 
general acid and protonates the released H277 and thus recycles the enzyme to its initial state. 
According to this mechanism, if a water molecule is used as the Ub acceptor in the second step, 
the reaction simply results in the cleavage of ADPR-Ub to PR-Ub.  
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Figure 2-12. A Mechanistic Model of 
Serine Ubiquitination catalyzed by 
the PDE Domain of SdeA. A two-step 
reaction model of SdeA catalyzed 
serine ubiquitination is proposed here. 
The first step involves the formation of 
a transient PR-Ub~enzyme 
intermediate and the cleavage of the 
phosphoanhydride bond of ADPR-Ub. 
The second step involves the formation 
of a phosphoester bond between PR-Ub 
and a substrate serine residue. 
 
 
 
 
 
Our data showed that the ubiquitination of Rab33b is overall fairly inefficient, which is in 
agreement with previously reported results that the cleavage of ADPR-Ub is apparently much more 
efficient than the conjugation of PR-Ub to substrate proteins [7]. This observation can be explained 
by the accessibility of the catalytic groove. A small water molecule is much easier to access the 
catalytic site located in a deep groove than a bulky protein substrate. Even for protein substrates, 
it is likely that only the serine residues located at protruding loops are able to access the catalytic 
site on the PDE domain. In fact, Residue S154 of Rab33b, which has been shown to be the 
ubiquitinated by SdeA [7], is located at the tip of a protruding loop on Rab33b [31].  
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SdeD and SdeA, in comparison, share a very similar fold. The major difference is the 
location of two different loops that cover the active cleft of these PDE domains: the loop between 
residues 26 and 48 of SdeD is missing within SdeA PDE domain and the loop between residues of 
465 and 513 of SdeA is completely gone within the SdeD PDE domain. The difference of location 
of these loops in PDE domains might be the underlying reason why SdeD can bind to Ub much 
tighter than SdeA and how SdeA might recognize target proteins and SdeD can not. In addition to 
the loop difference, the ubiquitin recognition surface of SdeD is not conserved in SdeA and other 
large SidE family members. As discussed in more detail in Chapter 3, all these PDE domain 
differences might be important for the consecutive activity of these proteins during infection.  
The presence of a Mid domain was not expected from previous bioinformatical predictions. 
Regarding the placement of the domain between two other functioning domains, we first predicted 
it to have a carrier function. The function independence experiment and mutational analysis on the 
Mid domain itself showed the importance of the domain only for the first step of ubiquitin 
modification. The evolutionary reason behind the presence of this Mid domain is not clear, because 
the domain’s fold is not conserved among other protein structures. When we searched for a similar 
fold with Dali Server, we could not find a match with a score above the threshold. Also, when we 
compare the mART domain of SdeA to other mART domain containing bacterial effector proteins, 
we observe the target recognition motif of other effectors is missing in SdeA. Evolutionarily, 
Legionella might have obtained a fold that recognizes ubiquitin and over time this domain might 
have evolved to this unique fold. The essentiality of this domain can be tested by using the Mid 
domain deleted full-length construct for Legionella infection reactions.  
SdeA protein has been shown to be highly toxic with previous yeast toxicity assays [32]. 
The reason behind the toxicity of the protein is prone to discussion: the toxicity might be either 
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because of the depletion of available ubiquitin to the conventional ubiquitination pathway or the 
PR-ubiquitination of the target proteins and their inactivation. The target inactivation by novel 
ubiquitination seems not to be real for Rab33b molecule since the protein’s GTPase activity is not 
lost upon PR-ubiquitination in vitro [33]. The exact effect of the PR-ubiquitin modification needs 
to be elucidated thoroughly. The targets, upon modification, might change localization or their 
interaction with other proteins. These possibilities can be observed both in vivo with mammalian 
cell overexpression of SdeA and monitoring target proteins or even observing the target proteins 
during infection conditions. The possibility of ubiquitin depletion can be tested by looking at the 
modified levels of ubiquitin during infection. Ubiquitin levels don’t fluctuate to a big degree within 
cell homeostasis [34], so the modified ubiquitin might be present only for a short period of time 
during infection. A pulse-chase experiment of ubiquitin modification might shed more light on 
this depletion possibility.  
Given the fact that many Legionella effector proteins have eukaryotic origins 
evolutionarily[35], it is likely that eukaryotes also harbor an equivalent machinery to perform 
PR-ubiquitination. Future elucidation of such a eukaryotic enzyme system is of fundamental 
significance to our understanding of the versatile Ub code. 
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2.4 MATERIALS AND METHODS 
Cloning and Mutagenesis.  
DNA fragments encoding SdeA (aa. 211-910) and SdeD (a.a. 1-341) were amplified from 
L. pneumophila genomic DNA. The PCR products were digested with BamHI and XhoI restriction 
enzymes and inserted into a pET28a-based vector in frame with an N-terminal 6xHis-SUMO tag 
for protein overexpression in bacteria cells. Amino acid substitutions of SdeA and SdeD were 
introduced by site-directed mutagenesis using oligonucleotide primer pairs containing the 
appropriate base changes. DNA fragments encoding wild type or mutant Ub were PCR amplified 
and subcloned into a pET21a vector. All constructs were confirmed by DNA sequencing.  
 
Protein Expression and Purification. 
For expression of SdeA and SdeD proteins, E. coli BL21-DE3 strains harboring the 
expression plasmids were grown in Luria-Bertani medium supplemented with 50 μg/ml kanamycin 
to mid-log phase. Protein expression was induced for overnight at 18°C with 0.1 mM isopropyl-
B-D-thiogalactopyranoside (IPTG). Harvested cells were resuspended in a buffer containing 20 
mM Tris-HCl (pH 8.0), 150 mM NaCl) and were lysed by sonication. Soluble fractions were 
collected after centrifugation at 16,000 rpm for 30 min at 4°C and incubated with cobalt resins 
(Clonetech) for 1.5 h at 4°C. Protein bound resins were extensively washed with lysis buffer. The 
SUMO-specific protease Ulp1 was then added to the resin slurry to release SdeA proteins from 
the His-SUMO tag. Eluted protein samples were further purified by FPLC size exclusion 
chromatography. FPLC fractions corresponding to the protein peak were pooled and the purified 
proteins were concentrated to 10 mg/ml. Protocols for Ub expression and purification were adapted 
from publish literatures [36]. Briefly, harvested cells were resuspended in a buffer containing 20 
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mM ammonium acetate (pH 5.1). Cells were lysed by sonication and cell lysate was clarified by 
18.000 rpm centrifugation for 30 min. Clarified supernatant was pooled and was titrated gradually 
with acetic acid to lower the pH to 4.8. Precipitated proteins after the titration were removed by 
centrifuged at 18.000 rpm for 30 min. The pH of the clarified supernatant was adjusted to 5.1 by 
NaOH addition. HiTrap SP column (GE Healthcare) was used for cation exchange with a buffer 
gradient from 20 mM ammonium acetate to 0.5 M ammonium acetate (both pH: 5.1). Fractions 
containing ubiquitin peak were pooled and was further purified with a size exclusion 
chromatography in 150 mM NaCl, 20 mM Tris pH 7.5. Ubiquitin-containing fractions were pooled 
and concentrated. 
To prepare ADPR-Ub for both biochemical assays and crystallographic trials, 1 μM of 
SdeA (211-910) H277A (which lacks PDE activity, see Figure 5D) was incubated with 25 μM Ub 
and 1 mM NAD+ for 1 h at 37°C.  ADPR-Ub was purified by size exclusion chromatography in 
150 mM NaCl, 20 mM Tris pH 7.5. 
 
Protein Crystallization. 
Generally, all protein crystallization screens were performed with a Crystal Phoenix liquid 
handling robot (Art Robbins Instruments) at room temperature. The crystallization, which yields 
the initial crystals from the screen, were further optimized by the hanging-drop vapor diffusion 
method by mixing 1.5 µl of protein with an equal volume of reservoir solution.  
Specifically, For SdeA crystallization, SdeA was concentrated to 12 mg/ml and crystallized 
in 100 mM HEPES pH 7.9, 12% PEG 8000. Thin-plate shaped SdeA crystals appeared in about 
two weeks. For SdeD crystallization, SdeD was concentrated to 14 mg/ml and crystallized in 200 
mM CaCl2, 100 mM MES pH 5.5, 18% PEG 6000, and 100 mM DTT. Cube shaped crystals 
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formed within 2-3 days. To generate the SdeD-Ub crystals, SdeD (1-341) was mixed with WT-Ub 
at a 1:5 molar ratio, with a final SdeD concentration of 8 mg/ml. Rod-shaped crystals formed in 
200 mM NaCl, 100 mM imidazole pH 7.0, and 24% PEG 8000. The SdeD/Ub/ADPR-Ub co-
crystal was formed by mixing a catalytically inactive mutant SdeD (a.a. 1-341, H67A) with ADPR-
Ub and WT-Ub in a 1:2:3 molar ratio, with a final SdeD concentration of 12 mg/ml. Rod-shaped 
crystals appeared in 100 mM sodium cacodylate pH 6.7 and 21% PEG 8000.  
 
X-ray Diffraction Data Collection, and Processing. 
Diffraction data sets for SdeA, the SdeD-Ub complex, and the SdeD/Ub/ADPR-Ub 
complex data sets were collected at Cornell synchrotron light source MacChess beam line F1, 
while data sets for SdeD crystals were collected at the A1 beam line (Table 2-1).  Before data 
collection, all crystals were soaked in cryo-protectant solutions containing their respective 
crystallization condition buffer supplemented with 20% glycerol and flash frozen in liquid nitrogen 
stream. All data sets were indexed, integrated and scaled with HKL-2000 [37].  
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Table 2-1: X-Ray Crystallography Data Collection and Refinement Statistics 
Structure Determination and Refinement. 
The structure of SdeA was solved by single wavelength anomalous dispersion (SAD) 
method. Before data collection, SdeA crystals were soaked in cryoprotectant (0.1 M Hepes pH 7.9, 
12% PEG8000 and 25% (v/v) glycerol) with the addition of 10 mM ethylmercury chloride for 5 
min at room temperature. Heavy atom sites were determined and initial phase was calculated using 
the program HKL2MAP [38]. The structure of the PDE domain of SdeD was solved by SAD 
phasing with seleno-methionine incorporated SdeD crystals. The structures of the SdeD-Ub and 
SdeD/Ub/ADPR-Ub complexes were solved by molecular replacement with the AMoRe program 
59 
 
[39] of the CCP4 suite [40], using the apo SdeD structure as the search model. For all data sets, 
iterative cycles of model building and refinement were carried out with Coot [41] and refmac5 
[42] of the CCP4 suite.  
Computational Analysis and Graphic Presentation of Protein Sequence and Structure. 
SdeA homologous sequences were selected from results generated by BLAST server 
(NCBI). Edited sequences were aligned with Clustal Omega [43] and colored by Multiple Align 
Show online server (http://www.bioinformatics.org/sms/index.html). Protein surface conservation 
was calculated by the online ConSurf server (http://consurf.tau.ac.il) [26]. All structural figures 
were generated using PyMOL (The PyMOL Molecular Graphics System, Version 1.8.X, 
Schrödinger, LLC). 
   
Ubiquitin Modification and Rab33b Ubiquitination Assays.  
Ubiquitin modification reactions were carried out by mixing 1 μM of SdeA with 25 μM 
ubiquitin in a reaction buffer containing 50 mM NaCl and 50 mM Tris pH 7.5, in the presence or 
absence of 1 mM NAD+.  The reactions were incubated for 1h at 37°C and reaction products were 
assessed by both 8% native PAGE and SDS-PAGE. Native gels were stained with Coomassie, 
while SDS-PAGE gels were stained with Pro-Q Diamond phosphoprotein stain (Invitrogen) to 
assay for PDE activity. Rab33b ubiquitination reactions were performed by the addition of 4 μM 
of recombinant Flag-Rab33b to the ubiquitin modification reaction described above. The reaction 
products were analyzed by SDS-PAGE followed by Western blot using an anti-Flag antibody 
(Sigma-Aldrich) at a 1:2500 dilution. 
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CHAPTER 3 
SdeD-SdeF DEUBIQUITINATES SdeA TARGETED PROTEINS TO REGULATE SdeA 
ACTIVITY 
 
3.1 ABSTRACT 
During infection, Legionella manipulates host cellular processes in a highly regulated 
manner. Ubiquitination, a post-translational modification that is involved in the regulation of 
various cellular pathways, is modulated by Legionella effector proteins for the continuation of 
infection. SidE family effector proteins have recently been shown to possess a novel ubiquitination 
mechanism that includes addition of a phosphoribose moiety to a ubiquitin molecule with their 
mono ADP ribosyltransferase (mART) and phosphodiesterase (PDE) domains. The SidE protein 
family consists of four large members that have both mART and PDE domains, but there are five 
smaller proteins that share the PDE domain alone. The function of this stand-alone PDE domain 
is not known. In this study, we observed that the small SdeD and SdeF proteins from SidE family 
do not target the proteins that SdeA does, but instead act as deubiquitinase (DUB) enzymes that 
remove the phosphoribosyl-ubiquitin from target proteins of SdeA. The DUB activity is shown 
both by a single target, Rab33b, or targets from the whole cell lysate. We have also observed a 
Golgi fragmentation phenotype when SdeA is present in mammalian cells. We have shown the 
reversion of this phenotype by SdeD-SdeF proteins. We have found a candidate for ubiquitination 
and Golgi fragmentation link, Syntaxin 5. We have shown the modification of Syntaxin 5 by SdeA 
and the DUB activity of SdeD-SdeF on this protein, both in vivo and in vitro. Our results suggest 
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a DUB activity of SdeD-SdeF proteins against the target proteins of large SidE protein family 
members. This DUB activity may be used by Legionella to revert the effects of SidE proteins to 
create a distinctive regulation of activity before and after the formation of Legionella-containing 
vacuole (LCV).  
3.2 INTRODUCTION 
Ubiquitination is a posttranslational modification that is involved in a wide range of 
pathways including protein degradation, inflammation, endocytosis, histone regulation, DNA 
repair and cell cycle [1-4]. The conventional ubiquitination signal cascade follows a three-step 
reaction: a ubiquitin activation step by E1 enzyme, a ubiquitin conjugating step by E2 enzyme, 
and a ubiquitin ligation step by an E3 enzyme [5]. The C-terminal glycine residue of ubiquitin gets 
activated by linking to the active cysteine residue of E1 enzyme through a thioester bond. This 
reaction needs ATP and Mg as cofactors. E1 enzyme transfers Ub molecule to E2 again by 
thioester linkage. Finally, E3 enzyme directly or indirectly transfers the ubiquitin to the target 
protein from the activated E2 enzyme [6]. The ubiquitin pathway is found only in eukaryotic cells 
[7], but microbial pathogens have been observed to secrete proteins into host cells that interferes 
with this pathway [8]. Pathogenic bacteria Salmonella, Shigella, Chlamydia, Pseudomonas and 
Legionella secrete effector proteins that either act as a bacterial E3 ligase (BEL) or act on the 
ubiquitinated proteins and act as a deubiquitinase (DUB) [9]. SidE protein family secreted by 
Legionella have been reported to ubiquitinate target proteins via a novel mechanism without the 
need of conventional ubiquitination enzymes [10]. The monoADP-ribosylation (mART) domain 
of SidE proteins transfers an ADP-ribosyl moiety (ADPR) to the R42 residue of ubiquitin using 
the NAD molecule as a cofactor and releasing nicotinamide; and the phosphodiesterase (PDE) 
domain cleaves the AMP from the ADPR moiety and ligates the phosphoribosylated (PR) ubiquitin 
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to the serine residue of target proteins [11, 12]. SidE members also contain a conventional DUB 
domain that cleaves the K42 and/or K63 linked ubiquitin from a very broad range of proteins [13]. 
The biochemical mechanism of both mART and PDE domains remains elusive. In the previous 
study that was detailed in Chapter 2, our lab has successfully solved the mechanism of PDE and 
how the target is PR-ubiquitinated. We have identified a new domain between mART and PDE 
domains and named it as Mid domain that helps with the activity of mART domain.  
The sole function of secreted effectors is not to act on host pathways. Metaeffectors are 
proteins that regulate the activity of other effector proteins during infection [14]. The metaeffector 
activity can be on the other effectors directly as in the case of LubX ubiquitinating other effector 
protein SidH [15], or the activity can be on the substrates or the products of the other effector 
proteins. A well-known example is the modulation of Rab1 during infection: AnkX effector 
protein adds a phosphocholine (PC) moiety to Rab1 [16] and Lem3, and at a later stage of the 
infection, removes that moiety [17]. SidM adds an AMP molecule to Rab1 [18] and SidD protein 
arrives and removes AMP again at a later stage [19]. Even earlier than the report on the activity of 
the SidE proteins, SidJ effector has shown to be a metaeffector for SidE family members in a yeast 
survival assay [20]. A later report on SidJ showed that the protein can cleave the PR-ubiquitin 
modification of SdeA from the target proteins and act as a deubiquitinase for SidE ubiquitination 
[21].  
SidE protein family contains five other proteins (lpg1496, lpg2509, lpg2154, lpg2239, and 
lpg2523) that share the PDE domain with the other four members (SidE, sdeA-C) (see Figure 1-
3). With the activity of SidJ cleaving the ubiquitin from the targets revealed, we wondered what 
the proteins that have the PDE domain alone can do during infection. In this study, we have shown 
that small SidE members, lpg2509 (sdeD) and lpg2154 (sdeF) can act on ADPR-ubiquitin to make 
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PR-Ub and these two proteins can cleave the PR-Ub molecule from SidE targeted proteins both in 
vitro and in vivo. We observed that overexpression of SdeA protein causes Golgi fragmentation 
and when SdeD or SdeF is overexpressed with SdeA together, the phenotype is gone. During 
mitosis, Golgi fragmentation is regulated by the ubiquitination state of SNARE proteins [22]. It is 
well established that the SNARE protein Syntaxin5 (Stx5) gets ubiquitinated by HACE1 during 
mitosis and deubiquitinated by the VCIP135 complex to form the fully functional Golgi [23]. We 
showed that SdeA PR-ubiquitinates Stx5 and SdeD, SdeF proteins deubiquitinate Stx5, both in 
vivo and in vitro. This “metaeffector” activity of smaller SidE members provides information about 
how the PR-ubiquitination of SidE members can be regulated. This might help to revert the initial 
infection steps during LCV formation and let the host cell recover until Legionella continues its 
development hiding inside the LCV.  
3.3 RESULTS 
SdeD and SdeF can act on ubiquitin, but not on target proteins 
SidE protein family shares the PDE domain in all its members. When the sequences are 
aligned, the active site residues are observed to be conserved in all the proteins (Figure 3-1). With 
this conservation, we were curious if the small PDE proteins will also share the same activity. To 
test, we synthesized ADPR-Ub by incubating ubiquitin with PDE-dead mutant of SdeA core 
protein (210-911 aa.). When incubated with ADPR-Ub, PDE domains of SdeA, SdeD and SdeF 
can all remove the AMP moiety from the ADPR-Ub as shown with Pro-Q Diamond 
Phosphoprotein Stain (Figure 3-2 A).  
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Figure 3-1: Multiple Sequence Alignment of the PDE Domain. Representative sequences 
corresponding to the PDE domain of SdeA (aa. 222-502) were aligned by MultiAlin [24]. Entrez 
database accession numbers are as follows: SdeA, GI: 1064303039; SidE, GI: 52840489; SdeB, 
GI: 52842367; SdeC, GI: 52842370; lpg2154, GI: 52842368; and SdeD, GI: 52842717. Secondary 
structural elements are drawn above the alignment. The numbering for the SdeA sequence is 
marked on the top of the alignment and the numbering for the SdeD sequence is marked below. 
The three essential catalytic residues are highlighted with stars. 
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Next, we wanted to see if SdeD and SdeF can ubiquitinate target proteins. Rab33b (shown to be 
target of SdeA [25]) and whole cell lysate (WCL) from HEK293T cells were incubated with the 
designated PDE domain proteins and ADPR-Ub proteins. To our surprise, we observed that only 
the PDE domain of SdeA can PR-ubiquitinate the target proteins in both Rab33b and WCL proteins 
(Figure 3-2 B and C).  
Figure 3-2: SdeD-SdeF Activity on Ubiquitin and SdeA Targets. (A) In vitro Phosphodiesterase 
activity assay. Cleavage of AMP by PDE domains can be monitored by Pro-Q Diamond 
Phosphoprotein staining of Ub on SDS gel. (B) Rab33b modification by PDE domains. Purified 
Flag-Rab33b was mixed with ADPR-Ub and indicated PDE domains of SidE family members. 
Reaction products were observed by immunoblotting against Flag antibody. (C) Modification of 
proteins in whole cell lysate. The same experimental set-up was used as in (B), but instead whole 
cell lysate from HEK293T cells were mixed with HA-ADPR-Ub and indicated PDE domains. The 
reaction products were run on SDS-PAGE and analyzed by immunoblotting against HA antibody 
(the PDE dead mutant proteins were used to compare with following results).  
SdeD and SdeF interact with ubiquitin and ubiquitinated proteins 
The activity difference of SdeA-SdeD PDE domains can be traced back to the structural 
differences. When we compare the two domains, we see two different “lids” above the catalytic 
grooves: the extensions from the catalytic grooves stay on different sides of the catalytic residues 
(see Figure 2-8 for details). This might be the structural constraint of SdeD to reach to the serine 
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residue of the target protein. The differing localization of the lid might also be the reason why 
SdeD can bind to very strongly to ubiquitin but SdeA cannot. Even though we could not crystallize 
the PDE domain of SdeA with ubiquitin, the complex could be obtained with SdeD PDE domain. 
To show Ub-sdeD physical interaction, we wanted to do co-immunoprecipitation. SdeD protein 
gets ubiquitinated when transfected in HEK293T cells (data not shown), so we did tandem 
immunoprecipitation. We incubated bead-bound HA-Ubiquitin transfected cell lysate with GFP-
SdeD transfected cell lysate. Only SdeD could interact with ubiquitin and ubiquitinated proteins 
(Figure 3-3 A).  
Figure 3-3: SdeD-SdeF Can Interact with Ub and Ubiquitinated Proteins. (A) Interaction of 
SdeD with ubiquitinated proteins. Whole cell lysate from HEK293T cells with HA-Ub transfection 
were lysed and pulled down with HA-beads. The bound proteins were further mixed with either 
GFP or GFP-SdeD containing whole cell lysates. Beads were re-washed after second incubation 
and samples were run on SDS-PAGE. Analysis was done by immunoblotting against anti-HA and 
anti-GFP antibodies. (B) Ubiquitination pattern change by SdeD-SdeF o/e. HA-Ub and designated 
GFP tagged protein containing HEK293T cells were lysed and whole cell lysates were run on 
SDS-PAGE. The analysis was done by immunoblotting against anti-HA and anti-GFP. 
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SdeD and SdeF act as deubiquitinase on SdeA target proteins 
When co-transfected with ubiquitin, SdeD and SdeF cause elevated levels of ubiquitinated 
proteins compared to PDE domain of SdeA alone (Figure 3-2 B). This was interesting since 
overexpression of SdeA PDE domain did not change the ubiquitination levels (data not shown). A 
recent finding about the metaeffector protein SidJ shows the deubiquitinase activity against PR-
ubiquitinated proteins [21]. We wondered whether the PDE domains of SdeD and SdeF can 
perform deubiquitination activity. To test, we PR-ubiquitinated Rab33b protein with ADPR-Ub 
and SdeA PDE domain and later added SdeD or SdeF wild type or PDE-dead mutants. Both SdeD 
and SdeF PDE domains could cleave the PR-Ub from Rab33b (Figure 3-4 A). We repeated the 
same experiment with HEK293T cells, WCL was incubated with HA-ADPR-Ub and SdeA PDE 
domain and further incubated with SdeD and SdeF proteins. We showed that the PR-ubiquitinated 
proteins were deubiquitinated by both SdeD-SdeF proteins (Figure 3-4 B). In both experiments, 
the PDE-dead mutants of SdeD and SdeF could not remove the PR-Ub, meaning that the DUB 
activity is related to their PDE function (Figure 3-4 A and B).  
Figure 3-4: SdeD-SdeF act as Deubiquitinase for SdeA Target Proteins. (A) In vitro DUB 
activity of PDE domains. Pre-incubated Rab33b samples with ADPR-Ub and SdeA PDE domain 
were further incubated with indicated SdeD-SdeF proteins. Samples were run on SDS-PAGE and 
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results were analyzed by immunoblotting against anti-Flag antibody. (B) Deubiquitination of PR-
ubiquitinated target proteins from whole cell lysate. Same experimental set up was used as in figure 
A. Whole cell lysate of HEK293T cells and HA-ADPR-Ub was used. Reaction products were run 
on SDS-PAGE and analysis was carried out by immunoblotting against anti-HA antibody.  
SdeA causes Golgi fragmentation & SdeD and SdeF can revert the phenotype 
The overexpressed SdeA protein is toxic to yeast and mammalian cells [20]. We wanted to 
see where SdeA is localized in HeLa cells to exert this toxic phenotype. To observe the 
localization, we co-transfected SdeA with different cellular markers and observed that the protein 
is localized mainly to the cytoplasm. Observing Golgi by immunostaining the Golgi marker 
GPP130 (Golgi Phosphoprotein 4 [26]), showed a more fragmented structure (Figure 3-5 A). This 
Golgi phenotype is dependent on the mART and PDE activities of SdeA: when we overexpressed 
the mART or PDE dead mutants of SdeA, there was no Golgi fragmentation observed (Figure 3-5 
A). We wondered if SdeD and SdeF could revert the phenotype observed by SdeA overexpression. 
When we co-expressed SdeA with either SdeD or SdeF WT proteins, the fragmentation phenotype 
was gone (Figure 3-5 B). This reversion phenotype is PDE-dependent because when we co-
expressed PDE dead mutants of SdeD and SdeF, the fragmentation phenotype by SdeA persisted 
(Figure 3-5 B).  
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Figure 3-5: SdeA Causes Golgi Fragmentation & SdeD-SdeF can Revert the Phenotype. (A) 
Golgi fragmentation by SdeA. HeLa cells were transfected with the corresponding GFP-tagged 
proteins. Fixed cells were immunostained with anti-Gpp130 antibody. Images were obtained by 
confocal microscopy. (B) Phenotype reversion by SdeD-SdeF. HeLa cells were transfected with 
the corresponding GFP and mCherry tagged proteins. Fixed cells were immunostained with anti-
Gpp130 antibody. Images were obtained by confocal microscopy. Zoomed-in boxes show the 
Golgi phenotype under designated transfection conditions.  
Syntaxin 5 is a target of SdeA and SdeD-SdeF  
We wanted to find a correlation between SdeA activity and Golgi fragmentation. A recent 
report suggested such a regulation of a SNARE protein, Syntaxin 5 (Stx5) during mitosis (Figure 
3-6 a). This study showed that Stx5 gets monoubiquitinated during early mitosis stages by the 
HACE1 E3 ubiquitin ligase whose activity was previously shown to be important for Golgi 
disassembly [27]. This modification inhibits interaction of Stx5 with its complementing SNARE 
protein, Bet1. This interaction is also important for ER to Golgi transport [28]. At later stages of 
mitotic cycle, the VCIP135 deubiquitinase protein, in complex with p97 and p47, removes the 
monoubiquitin from Stx5. This allows Stx5 to interact with Bet1 and Golgi assembly can start in 
daughter cells [23]. With this information, we wanted to test if Stx5 can be modified by SdeA. 
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Flag-Stx5 was co-transfected with WT and mutant SdeA constructs. Stx5 was not in a high amount 
in whole cell lysates (data not shown), so we immunoprecipitated Stx5 from co-transfected cells 
and checked for modifications by SdeA. As seen from figure 3-6 b, Stx5 is ubiquitinated by SdeA 
WT, but not with mART or PDE domain mutants. For the in vitro modification, we purified MBP 
tagged Stx5 with its C-terminal transmembrane region truncated (1-279) and incubated it with 
SdeA with or without NAD. As can be seen from Figure 3-7 B (first two lanes), SdeA can modify 
Stx5 the same way as in vivo (Figure 3-7 B).  
Figure 3-6: Syntaxin 5 is Modified by 
SdeA. (A) Schematic diagram of Syntaxin 5 
domain structure. N’ part of Stx5 contains 
three alpha helical bundles (Ha-c) and the C’ 
part contains the SNARE domain and the 
Transmembrane (Tm) domain. (B) 
Modification of Stx5 by SdeA. Flag-Stx5 and 
designated GFP constructs co-transfected 
HEK293T cells were lysed and Flag-Stx5 
was immunoprecipitated by anti-Flag beads. The eluates were run on SDS-PAGE and analyzed by 
immunoblotting against anti-Flag antibody.  
 
SdeA modifies the serine residues of its targets [11]. In this context, we wanted to find the residue 
that SdeA can modify on Stx5 protein. We mapped the serine residues that are localized on the 
SNARE domain of Stx5 (Figure 3-6 A) [29]. Individual and collective mutation of residues S278, 
S285 and S320 did not alter the modification of SdeA, meaning that the modified serine lies on 
another part of Stx5 (data not shown).  
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Figure 3-7: SdeD-SdeF can 
Remove PR-Ub from Stx5. (A) 
DUB activity of SdeD-SdeF in 
vivo. Flag-tagged Stx5 from cell 
lysates of indicated co-transfected 
HEK293T cells were 
immunoprecipitated. The eluates 
were run on SDS-PAGE and the 
analysis was carried out by 
immunoblotting against anti-GFP 
and anti-Flag antibodies. (B) In 
vitro PR-Ub removal by SdeD-
SdeF. Maltose-binding-protein 
(MBP) tagged Stx5 was mixed 
with SdeA and Ub with or without 
NAD in all the samples. Additional SdeD-SdeF constructs were added as indicated within the 
lanes. The reaction mixtures were run on SDS-PAGE and analyzed by Coomassie staining. All 
proteins were induced in and purified from E. coli.  
 
Next, we wanted to see if SdeD-SdeF can revert the SdeA modification on Stx5. We co-
transfected HEK293T cells with SdeA, SdeD (or SdeF) and Stx5. After the IP of Stx5, we observed 
that PR-Ub modification of Stx5 is reversed by SdeD-SdeF in a function-dependent manner 
(Figure 3-7 A). We further wanted to see if this PR-Ub removal by SdeD-SdeF can be replicated 
in vitro. Again, MBP tagged Stx5 was incubated with SdeA with or without NAD for one hour, 
and further incubated with SdeD-SdeF for another hour. Similarly, we observed that PR-Ub 
modification by SdeA on Stx5 was removed by the addition of SdeD-SdeF depending on their 
function (Figure 3-7 B). It was previously shown that SidJ can remove the PR-Ub form SdeA 
targets [21], so we wanted to see if this reversion by SdeD-SdeF is observed by SidJ as well. To 
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our surprise, the modification of Stx5 increased compared to other co-transfection conditions, 
instead of diminishing. This might be related to the high specificity of SidJ targeting (data not 
shown) [21]. 
3.4 DISCUSSION 
Previous studies on SdeA and other SidE family proteins show the biochemical activity of 
these proteins [10, 11]. There was no mention of the small SidE members, SdeD and SdeF, in these 
studies. The work described in this chapter argues that the proteins SdeD and SdeF acts as 
deubiquitinase enzymes against proteins that have a PR-Ub ligated by a SidE family member.  
When exposed to ADPR-Ub, the PDE proteins SdeD-SdeF could easily remove the AMP 
moiety from ubiquitin, but when either whole cell lysate or previously shown target protein 
Rab33b was incubated with these two proteins, no modification occurs. This led us to think that 
there should be another function to these PDE domains. The comparison between the PDE domains 
of SdeA and SdeD also proves some differences between these proteins: the loop between residues 
26 and 48 of SdeD is missing within SdeA PDE domain and the loop between residues of 465 and 
513 of SdeA is completely gone within the SdeD PDE domain. Both loops that create a difference 
cover the space above the active cleft. This difference of loop location might be the reason behind 
why SdeA can ubiquitinate proteins but SdeD can not. Testing the activity of SdeD and SdeA after 
replacing these loops with the counterparts from the other PDE domain might give us more clues 
as to how the PDE domain of SdeA can interact with its target proteins and how SdeD can bind to 
ubiquitin much tighter than SdeA.  
  A recent paper published about effector protein SidJ showed that the protein acts as a 
deubiquitinase against the proteins that are modified by SidE family [21]. The cleavage is shown 
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to be on the β-phosphate of the ADPR moiety which is the same bond that PDE domain targets. 
This led us to think that the PDE domains that are conserved in the small members SdeD-SdeF 
might have a similar function. We showed that SdeD-SdeF can act as a deubiquitinase against PR-
Ub conjugated proteins both in vivo and in vitro. This PR-Ub removal might be important during 
infection, since the first step of infection, LCV formation, requires different set of effectors 
compared to the second step of infection, LCV maturation and replication [30]. This antagonistic 
activity has already been reported for different Legionella effector proteins. The Rab1 host protein 
is first AMPylated by SidM molecule at early stages of LCV formation [19] and later gets 
deAMPylated by another effector protein SidD [17]. The activity of the targeted proteins by SdeA 
may be suspended by this modification during the formation of LCV, and at later stages of 
infection, SdeD and SdeF may reverse the suspension state of these proteins and let the host cell 
metabolism go back to normal. It is essential to pinpoint the exact secretion of these proteins during 
infection to shed more light on the activity regulation of these PDE domain-containing proteins.  
ER-to-Golgi destined anterograde vesicles form the outer layer of the LCV [31]. The 
morphology of Golgi has been observed to be intact throughout the infection even though vesicles 
destined for the Golgi are recruited by Legionella. We have observed a Golgi fragmentation 
phenotype when SdeA protein is overexpressed. This introduction of a possible “artificial” 
phenotype with overexpression is observed by many other effector proteins. When the Legionella 
effector protein LpdA, a phospholipase D molecule, is overexpressed in mammalian cells, Golgi 
shows a fragmented phenotype [32]. When we overexpressed SdeD and SdeF proteins in HeLa 
cells, we observed ubiquitin puncta structures that were missing in control cells (data not shown). 
During infection, Legionella secretes a small amount of each effector to the host cell. A study on 
VipD phospholipase effector protein showed a total of 500 molecules during infection [33]. This 
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might mean that when some of the effectors are overexpressed in mammalian cells, effects of these 
molecules might get exaggerated and some artifact phenotypes might be observed. Although, these 
artifacts may hint on the actual roles of these proteins during infection conditions. Monitoring the 
Golgi phenotype in a time-dependent manner with SdeA overexpression may help to understand 
the exact effect of SdeA on Golgi.  
Syntaxin 5 (Stx5) was predicted to be a candidate for SdeA Golgi phenotype regarding its 
ubiquitination state during mitosis. The ubiquitination of SNARE domain of Stx5 was shown to 
be crucial for interaction with its counterpart Bat1 SNARE protein [23]. For this reason, we 
mutated the serine residues that might be targeted by SdeA within the SNARE domain. The mono 
or triple mutation of these serine residues did not affect the ubiquitination by SdeA molecule. This 
means that another serine residue (or residues) gets modified by SdeA that might affect the activity 
of Stx5 in a different manner. The fragmentation of Golgi might not have anything with the 
modification of Stx5 protein. The next step should be trying to find more targets of SdeA by in 
vitro or in vivo methods that might relate the activity of SdeA to the Golgi phenotype.  
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3.5 MATERIALS and METHODS 
Cloning and Mutagenesis 
DNA fragments encoding SdeA (aa. 211-599), SdeD (a.a. 1-341) and SdeF (1-330) were 
amplified from L. pneumophila genomic DNA. The PCR products were digested with BamHI and 
XhoI restriction enzymes and inserted into a pET28a-based vector in frame with an N-terminal 
6xHis-SUMO tag for protein overexpression in bacteria cells. Amino acid substitutions of SdeA, 
SdeD and SdeF were introduced by site-directed mutagenesis using oligonucleotide primer pairs 
containing the appropriate base changes. DNA fragments encoding wild type or mutant Ub were 
PCR amplified and subcloned into a pET21a vector. All constructs were confirmed by DNA 
sequencing. The plasmids used for Rab33b and Syntaxin 5 experiments were provided by Zhao-
Qing’s lab in Purdue and Yanzhuang Wang’s lab in University of Michigan.  
Protein Expression and Purification 
For expression of SidE family proteins, E. coli BL21-DE3 strains harboring the expression 
plasmids were grown in Luria-Bertani medium supplemented with 50 μg/ml kanamycin to mid-
log phase. Protein expression was induced for overnight at 18°C with 0.1 mM isopropyl-B-D-
thiogalactopyranoside (IPTG). Harvested cells were resuspended in a buffer containing 20 mM 
Tris-HCl (pH 8.0), 150 mM NaCl) and were lysed by sonication. Soluble fractions were collected 
after centrifugation at 16,000 rpm for 30 min at 4°C and incubated with cobalt resins (Clonetech) 
for 1.5 h at 4°C. Protein bound resins were extensively washed with lysis buffer. The SUMO-
specific protease Ulp1 was then added to the resin slurry to release proteins from the His-SUMO 
tag. Eluted protein samples were checked by running SDS-PAGE. Protocols for Ub expression 
and purification were adapted from publish literatures [34]. Briefly, harvested cells were 
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resuspended in a buffer containing 20 mM ammonium acetate (pH 5.1). Cells were lysed by 
sonication and cell lysate was clarified by 18.000 rpm centrifugation for 30 min. Clarified 
supernatant was pooled and was titrated gradually with acetic acid to lower the pH to 4.8. 
Precipitated proteins after the titration were removed by centrifuged at 18.000 rpm for 30 min. The 
pH of the clarified supernatant was adjusted to 5.1 by NaOH addition. HiTrap SP column (GE 
Healthcare) was used for cation exchange with a buffer gradient from 20 mM ammonium acetate 
to 0.5 M ammonium acetate (both pH: 5.1). Fractions containing ubiquitin peak were pooled and 
was further purified with a size exclusion chromatography in 150 mM NaCl, 20 mM Tris pH 7.5. 
Ubiquitin-containing fractions were pooled and concentrated. 
To prepare ADPR-Ub for biochemical assays, 1 μM of SdeA (211-910) H277A (which 
lacks PDE activity) was incubated with 25 μM Ub and 1 mM NAD+ for 1 h at 37°C.  ADPR-Ub 
was purified by size exclusion chromatography in 150 mM NaCl, 20 mM Tris pH 7.5. 
For purification of 6xHis-Flag-Rab33b, the same protocol as for SidE proteins was 
followed. Instead of cleaving the protein tag with a protease, the protein was eluted with Elution 
buffer (20mM Tris, pH:8.0, 150mM NaCl and 400mM Imidazole). The eluted protein was 
concentrated and further purified by FPLC size exclusion chromatography. The peaks 
corresponding to the protein was pooled down and concentrated before the reaction.  
Purification of MBP-Syntaxin 5 followed the same protocol. Instead of using Cobalt beads, 
the protein was purified with Amylose Resin (New England Biolabs) and the protein was eluted 
with eluted with Elution buffer (20mM Tris, pH:8.0, 150mM NaCl and 100mM Maltose). 
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Computational Analysis and Graphic Presentation of Protein Sequence and Structure 
SidE family protein sequences were selected from results generated by BLAST server 
(NCBI). Edited sequences were aligned with Clustal Omega [35] and colored by Multiple Align 
Show online server (http://www.bioinformatics.org/sms/index.html). All structural figures were 
generated using PyMOL (The PyMOL Molecular Graphics System, Version 1.8.X, Schrödinger, 
LLC).  
Ubiquitin Modification and Rab33b & Whole Cell Lysate Ubiquitination Assays 
ADPR-Ubiquitin modification reactions were carried out by mixing 1 μM of PDE protein 
with 25 μM ubiquitin in a reaction buffer containing 50 mM NaCl and 50 mM Tris pH 7.5.  The 
reactions were incubated for 1h at 37°C and reaction products were assessed by SDS-PAGE. Gels 
were stained with Pro-Q Diamond phosphoprotein stain (Invitrogen) to assay for PDE activity. 
Rab33b ubiquitination reactions were performed by the addition of 4 μM of recombinant Flag-
Rab33b to the ubiquitin modification reaction described above. The reaction products were 
analyzed by SDS-PAGE followed by Western blot using an anti-Flag antibody (Sigma-Aldrich) at 
a 1:2500 dilution. Whole cell lysate was collected from a 10cm 100% confluent HEK293T cells. 
The cells were lysed by Lysis buffer (50mM Tris pH:7.5, 150mM NaCl, 1% Triton-X100). The 
concentration of the lysate was measured by NanoDrop (Thermo Scientific). Whole cell lysate 
modification by PDE domains were carried out by adding 25 μM HA-ADPR-Ub to 100 μg of cell 
lysate with 1 μM PDE proteins. The reaction mixture was incubated at 37oC for 1h and the samples 
were run on 12% SDS-PAGE. The analysis was done by Western blot and using anti-HA antibody 
(Sigma-Aldrich) at 1:10000 for immunoblotting.  
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SdeD-SdeF Deubiquitinase Assays 
4 μM Rab33b molecule was mixed with 1 μM SdeA PDE domain with 25 μM ADPR-Ub 
and incubated at 370C for 1h. 1 μM SdeD-SdeF constructs were added to the reacted tubes and re-
incubated at 370C for 1h. The reaction products were run on 12% SDS-PAGE and analysis was 
done by Western blotting by using anti-Flag antibody for immunoblotting. Whole cell lysate 
reactions were carried out by mixing 100 μg whole cell lysate with 1 μM SdeA PDE domain and 
25 μM HA-tagged ADPR-Ub. The reactions were incubated at 370C for 1h. 1 μM SdeD-SdeF 
constructs were added to the reacted tubes and re-incubated at 370C for 1h. The reaction products 
were run on 12% SDS-PAGE and analysis was done by Western blotting by using anti-HA 
antibody (Sigma Aldrich) for immunoblotting.  
Immunofluorescence of Golgi Fragmentation 
Cells were seeded on glass coverslips and fixed in 4% PFA/PBS for 15 min. Cells were 
washed twice with PBS and permeabilized in PBS containing 0.05% saponin and 3% BSA for 30 
min. Cells were immunostained with proper primary and secondary antibodies. Anti–rabbit 
GPP130 (Covance) antibodies were used at 1:500. Confocal images, acquired at room temperature, 
were taken using a CSU-X spinning disk microscope (Intelligent Imaging Innovations) with a 
spherical aberration correction device, 100×, 1.4 NA objective, on an inverted microscope (Leica), 
and acquired with a QuantEM EMCCD camera using Slidebook software (Intelligent Imaging 
Innovations).  
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In Vivo Syntaxin-5 Ubiquitination Assay 
HEK293T cells were grown on 6-well plates to 80% confluency and the transfections were 
carried out with PEI (Thermo Fisher). Cells were lysed with Lysis buffer (50mM Tris pH: 8.0, 150 
mM NaCl, 0.1% Deoxycholate, 1% Triton X-100, 1X PMSF, 1X EDTA-Free Protease Tablet from 
Roche) and cell lysate was collected after 20 min centrifugation. M2-Flag (Sigma Aldrich) beads 
were used to immunoprecipitate Syntaxin-5 protein. The samples were washed three times with 
Wash buffer (50mM Tris pH:8.0, 150mM NaCl, 1% Triton-X100) and the samples were eluted 
from the beads by boiling at 95oC. The input and eluate were run on 8% SDS-PAGE and analysis 
was carried out by western blotting by using anti-Flag antibody (Sigma Aldrich) for 
immunoblotting.  
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CHAPTER 4 
 
CONCLUDING REMARKS AND FUTURE DIRECTIONS 
 
Legionella pneumophila manipulates a wide array of host cellular processes during its 
lifecycle inside the host cell [1]. More than 300 effector proteins are secreted during this invasion 
phase and all these effector proteins are involved in forming the Legionella-containing vacuole 
(LCV) to let the bacteria replicate and develop within the host cytoplasm [2]. These effector 
proteins are tightly regulated and have a consecutive order of secretion/activity during infection 
[3-5]. They also possess a high redundancy as shown by various genomic deletion and infection 
studies [6-8]. There is a wide array of pathways modulated by these effector proteins: Small 
GTPases get post-translationally modified [9-12], autophagy is inhibited or enhanced according to 
the stage of infection [8, 13, 14], phospholipids, mostly phosphoinositides, get modified [15-17], 
and such.  Ubiquitination machinery is one of the pathways that is “sabotaged” by Legionella [18]. 
Conventional ubiquitination needs a three enzyme cascade to modify target protein; E1, E2 and 
E3 [19], and bacterial effector proteins have been observed to mimic the activity of E3 ligase 
proteins [18, 20-23]. Recent studies proved evidence for a new mode of ubiquitination by SidE 
effector family: a mono-ADP-ribosyl transferase (mART) domain adds a ADP-ribose moiety to 
ubiquitin molecule by using an NAD molecule, and a phosphodiesterase (PDE) domain removes 
the AMP molecule from the ADPR moiety and ligates the remaining phosphoribosylated ubiquitin 
to target proteins; Rab33b and Reticulon 4 have been proven to be targeted by SidE family by this 
88 
 
modification [24-26]. Even though SdeA’s function does is established, the question “how?” 
remains elusive.  
This study aims to understand the molecular mechanism of SdeA and how the activity is 
regulated. In the second chapter, we (with help from a PhD student in Mao lab, Jon Wasilko) show 
how the SdeA protein is acting on the ubiquitin molecule. First, we have solved the crystal structure 
of SdeA protein with its mART, PDE and Mid domains that together form the functional core. The 
Mid domain was not expected to be there because previous bioinformatical studies did not predict 
a domain between mART and PDE domains [27, 28]. The Mid domain is localized between PDE 
and mART domains with two long loops connecting it to these domains. Initial thought was the 
possibility of Mid domain transporting ubiquitin between the two domains, but we have shown 
that PDE and mART domains can function separately. We also wanted to see the minimal active 
part of the mART domain and showed that mART can function only when Mid domain is localized 
to a certain position by a part of the PDE domain anchoring Mid domain. In short, our studies 
showed that this new Mid domain is indispensable for the mART activity of SdeA. How Mid 
domain participate in the first reaction remains elusive. Different constructs that extend more to 
the C’ part of SdeA are being tested to see if it changes the activity. The essentiality of the Mid 
domain can also be tested by cloning the SdeA protein that lacks the Mid domain into Legionella 
and observing the survivability of the bacteria during infection. The mechanism of mART and how 
the protein recognizes Ub in the first place also remains elusive. More crystallization trials should 
be carried out to capture the mART domain with Ub and/or with NAD molecule. To help solve 
this, Small Angle X-Ray Scattering (SAXS) methods can also be utilized. With SAXS, the mART 
domain-ubiquitin interaction and the relative position of Ub to the active site can be observed.  
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To understand the molecular mechanism behind both mART and PDE reactions, we tried 
crystallization of mART and PDE domains extensively with their target molecules NAD, Ub and 
ADPR-Ub respectively. No crystals could be obtained. Previously, we had solved the crystal 
structure of another SidE protein family member, SdeD, that contains the PDE domain alone. 
When we compared the ubiquitin affinity of two PDE domains from SdeA and SdeD, we observed 
that PDE from SdeD can bind to ubiquitin whereas PDE domain from SdeA cannot. With the help 
of this binding information, we tried to and could obtain and solve the complex structure of SdeD 
with unmodified and ADPR-moiety ligated ubiquitin molecules. The ADPR moiety was captured 
within the active cleft of the protein and with further mutagenesis analysis, we had deciphered the 
reaction mechanism for the PDE activity. The mechanism of target protein recognition and transfer 
of PR-Ub to the target remain elusive. For this purpose, co-crystallization with the target proteins, 
i.e. Rab33b, can shed light on the mechanism. SAXS analysis can additionally give an idea to the 
binding site of target proteins to SdeA.  
In the third chapter, we (with help from a Post-Doctoral researcher in Mao lab, Min Wan) 
tried to elucidate the activity of SdeD-SdeF. SdeD-SdeF are members of SidE family and contain 
the shared PDE domain alone [6]. We initially proposed that these proteins can have the same 
function as other SidE PDE domains. SdeD-SdeF were both found to be active towards ADPR-Ub 
to cleave the AMP molecule, but they were not active against target protein, Rab33b, or any other 
protein in the whole cell lysate. A recent study showed the deubiquitinase (DUB) activity of 
another effector protein, SidJ, towards the target proteins of SdeA [25]. With this information, we 
wanted to test the possibility of SdeD-SdeF acting as specific DUB for PR-ubiquitinated proteins. 
Indeed, when incubated with PR-ubiquitinated proteins, SdeD-SdeF can cleave the modification 
from the β-phosphodiester bond. It was verified both for a single target protein Rab33b and 
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modified proteins in the whole cell lysate experiment. When the two PDE domains of SdeD and 
SdeA are compared, each PDE domain has a loop over the active cleft that the other PDE domain 
does not. This structural difference can be the reason why one domain modifies the targets and one 
removes that modification. Replacing the loops on these PDE domains or crystallizing SdeA PDE 
domain with a target protein can help to find the structural reason of this difference. Two different 
activities of the same PDE domain within different members of the SidE family can be a regulatory 
mechanism as well. SdeA-C can PR-ubiquitinate different sets of proteins for the initial stages of 
infection and SdeD-SdeF can revert this modification for the progression of the infection after the 
LCV is established and Legionella starts to “hide” from the host cytoplasm.  This phenomenon 
can be studied within infection conditions. If the PR modification of ubiquitin and PR-Ub 
modification of target proteins can be traced during infection, this should shed more light on the 
regulatory nature of this whole novel ubiquitination machinery.  
During our studies for the localization of SdeA inside the mammalian cells, we observed 
that the Golgi is fragmented into smaller vesicles. Activity of SdeA was found to be crucial for 
this phenotype since the mutant SdeA proteins failed to create fragmentation. When SdeD-SdeF 
was present in the cell with SdeA, this fragmentation phenotype was reverted. We tried to find a 
link between ubiquitination and Golgi fragmentation and found out about a SNARE protein named 
Syntaxin 5 [29]. This SNARE protein was observed to be mono-ubiquitinated during early stages 
to inhibit its interaction with its corresponding SNARE molecule, Bet1 [30]. Within the later stages 
of mitosis, Syntaxin 5 was observed to be deubiquitinated and interact with Bet1 to start the 
defragmentation [31]. With this information, we wanted to see if SdeA can modify Syntaxin 5. We 
have shown the modification of Syntaxin 5 both in vitro and in vivo by SdeA. SdeD-SdeF can also 
revert the modification on Syntaxin 5 as well. This modification of Syntaxin 5 can be the link 
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between Golgi phenotype and SdeA activity. This actual link yet remains to be elucidated. 
Modification status of Syntaxin 5 can be monitored during infection. Golgi is reported to stay 
intact during infection [32], but SdeA may exert a short window of phenotype during infection that 
could have been missed by previous studies. A time-lapse monitoring of both Golgi phenotype and 
Syntaxin 5 modification may shed more light on the role of SdeA during infection.  
In summary, in this thesis I have presented data that shows how SdeA modifies ubiquitin 
and target proteins. We have shown that PDE and mART domains can function independently 
and that a newly found Mid domain is essential for the mART activity. With the help of SdeD-
Ub complex crystal structures, we have deciphered how the PDE domain functions 
mechanistically. In addition to the activity of SdeA, we have shown how SdeD-SdeF proteins 
can act on ADPR-Ub but not add PR-Ub moiety to target proteins. We provided evidence that 
SdeD-SdeF proteins can act as DUB molecules to remove the PR-Ub modification from SdeA 
targeted proteins. With a cellular biology approach, we have shown the Golgi fragmentation 
caused by SdeA and how this phenotype is reversed by SdeD-SdeF proteins. We have found a 
possible link, Syntaxin 5, between the Golgi phenotype and SdeA activity. Altogether, this 
protein suggests a roadmap to understand how the ubiquitin pathway is modulated by SidE 
family and gives an additional role for SidE family proteins during infection (Figure 4-1).  
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Figure 4-1: Substrate Modification by SidE Family. Diagram representation of how SidE 
family might modify target proteins to regulate their activity during infection.  
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